Submitted URL: http://www.biopharma-reporter.com/
Effective URL: https://www.biopharma-reporter.com/
Submission: On February 26 via api from US — Scanned from DE

Summary

This website contacted 30 IPs in 4 countries across 21 domains to perform 119 HTTP transactions. The main IP is 151.101.194.137, located in United States and belongs to FASTLY, US. The main domain is www.biopharma-reporter.com.
TLS certificate: Issued by R3 on December 29th 2023. Valid for: 3 months.
This is the only time www.biopharma-reporter.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 151.101.66.137 54113 (FASTLY)
5 60 151.101.194.137 54113 (FASTLY)
14 2606:4700::68... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
1 2a02:26f0:480... 20940 (AKAMAI-ASN1)
3 2a00:1450:400... 15169 (GOOGLE)
2 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:225... 16509 (AMAZON-02)
1 34.107.184.21 396982 (GOOGLE-CL...)
1 2a00:1450:400... 15169 (GOOGLE)
1 2606:4700:440... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 13.80.151.158 8075 (MICROSOFT...)
4 2a02:26f0:480... 20940 (AKAMAI-ASN1)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 2a02:26f0:350... 20940 (AKAMAI-ASN1)
4 2a03:2880:f00... 32934 (FACEBOOK)
2 2001:4860:480... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
4 5 2620:1ec:21::14 8068 (MICROSOFT...)
1 13.107.42.14 8068 (MICROSOFT...)
3 167.235.124.59 24940 (HETZNER-AS)
3 2a03:2880:f17... 32934 (FACEBOOK)
1 2a00:1450:400... 15169 (GOOGLE)
2 3.92.120.28 14618 (AMAZON-AES)
1 2606:4700::68... 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
119 30
Apex Domain
Subdomains
Transfer
63 biopharma-reporter.com
www.biopharma-reporter.com
go.biopharma-reporter.com
2 MB
14 cookielaw.org
cdn.cookielaw.org — Cisco Umbrella Rank: 330
278 KB
7 cxense.com
cdn.cxense.com — Cisco Umbrella Rank: 5081
p1cluster.cxense.com — Cisco Umbrella Rank: 9874
comcluster.cxense.com — Cisco Umbrella Rank: 4631
id.cxense.com — Cisco Umbrella Rank: 10729
82 KB
6 linkedin.com
px.ads.linkedin.com — Cisco Umbrella Rank: 350
www.linkedin.com — Cisco Umbrella Rank: 615
px4.ads.linkedin.com — Cisco Umbrella Rank: 6418
3 KB
6 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 219
stats.g.doubleclick.net — Cisco Umbrella Rank: 85
164 KB
4 facebook.net
connect.facebook.net — Cisco Umbrella Rank: 176
78 KB
4 google.com
www.google.com — Cisco Umbrella Rank: 2
region1.analytics.google.com — Cisco Umbrella Rank: 2663
2 KB
3 facebook.com
www.facebook.com — Cisco Umbrella Rank: 102
234 B
3 google.de
www.google.de — Cisco Umbrella Rank: 6553
622 B
3 tinypass.com
experience.tinypass.com — Cisco Umbrella Rank: 8850
cdn.tinypass.com — Cisco Umbrella Rank: 6246
buy.tinypass.com — Cisco Umbrella Rank: 6723
117 KB
3 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 40
246 KB
2 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 31
21 KB
2 gstatic.com
fonts.gstatic.com
www.gstatic.com
242 KB
2 wrbm.com
footer.wrbm.com — Cisco Umbrella Rank: 246275
resources.wrbm.com — Cisco Umbrella Rank: 187493
6 KB
1 googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 106
1 licdn.com
snap.licdn.com — Cisco Umbrella Rank: 805
16 KB
1 piano.io
c2.piano.io — Cisco Umbrella Rank: 5636
1 KB
1 onetrust.com
geolocation.onetrust.com — Cisco Umbrella Rank: 554
315 B
1 jwplayer.com
cdn.jwplayer.com — Cisco Umbrella Rank: 2905
41 KB
1 adobedtm.com
assets.adobedtm.com — Cisco Umbrella Rank: 448
103 KB
1 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 32
1 KB
119 21
Domain Requested by
61 www.biopharma-reporter.com 6 redirects www.biopharma-reporter.com
14 cdn.cookielaw.org www.biopharma-reporter.com
cdn.cookielaw.org
4 px.ads.linkedin.com 3 redirects snap.licdn.com
4 connect.facebook.net www.biopharma-reporter.com
connect.facebook.net
4 cdn.cxense.com cdn.tinypass.com
cdn.cxense.com
3 www.facebook.com www.biopharma-reporter.com
3 www.google.de www.biopharma-reporter.com
3 stats.g.doubleclick.net www.googletagmanager.com
www.google-analytics.com
3 www.googletagmanager.com www.biopharma-reporter.com
www.googletagmanager.com
3 securepubads.g.doubleclick.net www.biopharma-reporter.com
securepubads.g.doubleclick.net
2 www.google-analytics.com www.biopharma-reporter.com
www.google-analytics.com
2 go.biopharma-reporter.com www.biopharma-reporter.com
go.biopharma-reporter.com
2 region1.analytics.google.com www.googletagmanager.com
2 www.google.com www.biopharma-reporter.com
1 buy.tinypass.com cdn.tinypass.com
1 pagead2.googlesyndication.com www.biopharma-reporter.com
1 id.cxense.com cdn.cxense.com
1 comcluster.cxense.com cdn.cxense.com
1 p1cluster.cxense.com cdn.cxense.com
1 px4.ads.linkedin.com www.biopharma-reporter.com
1 www.linkedin.com 1 redirects
1 snap.licdn.com www.googletagmanager.com
1 c2.piano.io cdn.tinypass.com
1 resources.wrbm.com www.biopharma-reporter.com
1 www.gstatic.com www.google.com
1 cdn.tinypass.com experience.tinypass.com
1 geolocation.onetrust.com cdn.cookielaw.org
1 fonts.gstatic.com fonts.googleapis.com
1 footer.wrbm.com www.biopharma-reporter.com
1 cdn.jwplayer.com www.biopharma-reporter.com
1 experience.tinypass.com www.biopharma-reporter.com
1 assets.adobedtm.com www.biopharma-reporter.com
1 fonts.googleapis.com www.biopharma-reporter.com
119 33
Subject Issuer Validity Valid
www.biopharma-reporter.com
R3
2023-12-29 -
2024-03-28
3 months crt.sh
cookielaw.org
Cloudflare Inc ECC CA-3
2023-04-01 -
2024-03-31
a year crt.sh
upload.video.google.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
assets.adobedtm.com
DigiCert Global G2 TLS RSA SHA256 2020 CA1
2023-07-11 -
2024-08-10
a year crt.sh
*.google-analytics.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2023-08-13 -
2024-08-12
a year crt.sh
www.google.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
jwplayer.com
Amazon RSA 2048 M02
2023-10-27 -
2024-11-23
a year crt.sh
footer.wrbm.com
GTS CA 1D4
2023-12-31 -
2024-03-31
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
onetrust.com
Cloudflare Inc ECC CA-3
2023-11-13 -
2024-11-12
a year crt.sh
*.wrbm.com
Go Daddy Secure Certificate Authority - G2
2023-12-05 -
2024-12-05
a year crt.sh
*.cxense.com
DigiCert TLS RSA SHA256 2020 CA1
2024-02-14 -
2025-02-14
a year crt.sh
piano.io
Cloudflare Inc ECC CA-3
2024-02-25 -
2024-12-31
10 months crt.sh
snap.licdn.com
DigiCert SHA2 Secure Server CA
2023-12-13 -
2024-12-12
a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2023-12-06 -
2024-03-05
3 months crt.sh
www.google.de
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
www.linkedin.com
DigiCert SHA2 Secure Server CA
2024-01-30 -
2024-07-30
6 months crt.sh
go.biopharma-reporter.com
R3
2024-01-16 -
2024-04-15
3 months crt.sh

This page contains 2 frames:

Primary Page: https://www.biopharma-reporter.com/
Frame ID: C2E4B33B456A712F2611DD2B6597695C
Requests: 116 HTTP requests in this frame

Frame: https://cdn.cxense.com/sp1.html
Frame ID: 5DB94B1AB178F0A68210BDB10575A1C4
Requests: 4 HTTP requests in this frame

Screenshot

Page Title

Biopharmaceutical Manufacturing, Upstream, Downstream processing newsSendHomeMenucloseSendBack toBack toBack toBack toBack toBack toUsercloseFacebookTwitterLinkedinBack ButtonFilter Button

Page URL History Show full URLs

  1. http://www.biopharma-reporter.com/ HTTP 308
    https://www.biopharma-reporter.com/ Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • //connect\.facebook\.([a-z]+)/[^/]*/[a-z]*\.js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Overall confidence: 100%
Detected patterns
  • <!-- (?:End )?Google Tag Manager -->
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js

Overall confidence: 100%
Detected patterns
  • snap\.licdn\.com/li\.lms-analytics/insight\.min\.js

Overall confidence: 100%
Detected patterns
  • cdn\.cookielaw\.org
  • otSDKStub\.js

Overall confidence: 100%
Detected patterns
  • /recaptcha/api\.js

Page Statistics

119
Requests

95 %
HTTPS

77 %
IPv6

21
Domains

33
Subdomains

30
IPs

4
Countries

2948 kB
Transfer

6852 kB
Size

33
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://www.biopharma-reporter.com/ HTTP 308
    https://www.biopharma-reporter.com/ Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 8
  • https://www.biopharma-reporter.com/content/download/3061/9283809?version=11 HTTP 302
  • https://www.biopharma-reporter.com/content/download/3061/logo_prestitial/bpr.png?version=11
Request Chain 9
  • https://www.biopharma-reporter.com/content/download/3061/18689?version=11 HTTP 302
  • https://www.biopharma-reporter.com/content/download/3061/logo/bpr-logo.svg?version=11
Request Chain 10
  • https://www.biopharma-reporter.com/content/download/3061/4362127?version=11 HTTP 302
  • https://www.biopharma-reporter.com/content/download/3061/logo_mobile/bpr-logo.svg?version=11
Request Chain 20
  • https://www.biopharma-reporter.com/content/download/3061/9283809?version=11 HTTP 302
  • https://www.biopharma-reporter.com/content/download/3061/logo_prestitial/bpr.png?version=11
Request Chain 21
  • https://www.biopharma-reporter.com/content/download/3061/18689?version=11 HTTP 302
  • https://www.biopharma-reporter.com/content/download/3061/logo/bpr-logo.svg?version=11
Request Chain 93
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true HTTP 302
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D197740%26time%3D1708968038305%26li_adsId%3D6d8a1820-ea58-4de1-b69a-a57d8d836dbe%26url%3Dhttps%253A%252F%252Fwww.biopharma-reporter.com%252F%26cookiesTest%3Dtrue%26liSync%3Dtrue HTTP 302
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true&liSync=true HTTP 302
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true&liSync=true&e_ipv6=AQIZZjL98Aq4xgAAAY3mbtIGUNvAosIt64J9vhpvDqYuZjvd9_5KEVoya1hamp-kzLwntjJO

119 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request /
www.biopharma-reporter.com/
Redirect Chain
  • http://www.biopharma-reporter.com/
  • https://www.biopharma-reporter.com/
105 KB
27 KB
Document
General
Full URL
https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
14c8c0db7f4a7abe86384e0125d6eda0ddd571b0effc3d964cda37f5607b75c5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

accept-ranges
none
age
15379
cache-control
max-age=3600, public
content-encoding
br
content-type
text/html; charset=UTF-8
date
Mon, 26 Feb 2024 17:20:37 GMT
strict-transport-security
max-age=31536000; includeSubDomains
traceresponse
00-17b76b63728fec50712d0754a61c9489-1f15d566043a3591-01
vary
Accept-Encoding
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-xss-protection
1; mode=block

Redirect headers

Accept-Ranges
bytes
Connection
close
Content-Length
0
Date
Mon, 26 Feb 2024 17:20:37 GMT
Location
https://www.biopharma-reporter.com/
Retry-After
0
OtAutoBlock.js
cdn.cookielaw.org/consent/3649966f-cab2-4eb8-af76-2efa9af8e3a7/
30 KB
7 KB
Script
General
Full URL
https://cdn.cookielaw.org/consent/3649966f-cab2-4eb8-af76-2efa9af8e3a7/OtAutoBlock.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2bdc689f16939b79297dcdd1fa716571c3324a23fca2513b67e5e41a0f49ce44
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
strict-transport-security
max-age=31536000; includeSubDomains; preload
age
21746
content-md5
oRQ/Xzppa5yrw/XTpVgEPg==
content-length
6410
x-ms-lease-status
unlocked
last-modified
Mon, 12 Feb 2024 10:46:16 GMT
server
cloudflare
etag
0x8DC2BB7D71C2C5E
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
*
x-ms-request-id
c11c357d-701e-009c-2ca0-5d94e5000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1b5f1d926e-FRA
expires
Tue, 27 Feb 2024 17:20:37 GMT
otSDKStub.js
cdn.cookielaw.org/scripttemplates/
21 KB
7 KB
Script
General
Full URL
https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5be2dfa172d505acb197760b55c4731347cc239a7a046013c251948bb8214dbc
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
OKrCs7nhvutcs03VCUskmw==
age
39952
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-length
6841
x-ms-lease-status
unlocked
last-modified
Mon, 26 Feb 2024 02:34:49 GMT
server
cloudflare
etag
0x8DC3673814A08A2
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
x-ms-request-id
5c85c90d-101e-007e-7f61-68a9c4000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1b5f1c926e-FRA
css2
fonts.googleapis.com/
9 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
77190354256d2bb6e2f740715bbc72c1af70ec722773ab27bd7ddd63dac90529
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Mon, 26 Feb 2024 16:48:56 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Mon, 26 Feb 2024 17:20:37 GMT
9fd7a26.css
www.biopharma-reporter.com/css/
21 KB
5 KB
Stylesheet
General
Full URL
https://www.biopharma-reporter.com/css/9fd7a26.css
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
d98d3664d65f25d02d1765f4a79e7e7e1ddd7a3a7341c17cd89351a5525a0a20
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 06 Feb 2024 07:28:49 GMT
age
395993
traceresponse
00-17b3a52b273568f3724355bde81c909c-7eae7a8df28b3f01-01
etag
W/"65c1dfb1-552d"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=7200
accept-ranges
bytes
content-length
5136
expires
Wed, 14 Feb 2024 07:58:08 GMT
ea7361b.css
www.biopharma-reporter.com/css/
221 KB
70 KB
Stylesheet
General
Full URL
https://www.biopharma-reporter.com/css/ea7361b.css
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
a356e5ce41481aa26d70f4398dc1397074915dfed1bae7a809139bfc982567b3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 06 Feb 2024 07:28:50 GMT
age
285114
traceresponse
00-17b5d1c60a9288da3405d4e9d901f471-9f722a2a059887c5-01
etag
W/"65c1dfb2-37294"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=7200
accept-ranges
bytes
content-length
71035
expires
Wed, 21 Feb 2024 09:58:02 GMT
559e323.js
www.biopharma-reporter.com/js/
85 KB
30 KB
Script
General
Full URL
https://www.biopharma-reporter.com/js/559e323.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
87083882cc6015984eb0411a99d3981817f5dc5c90ba24f0940420c5548d82de
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 29 Jan 2024 07:47:21 GMT
age
2057533
traceresponse
00-17b02a0f7727f06745aa9241cf1e35ca-7c965fe81b162755-01
etag
W/"65b75809-15283"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=7200
accept-ranges
bytes
content-length
30178
expires
Fri, 02 Feb 2024 23:48:24 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
89 KB
29 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
228a2f138a2366442e25896f781a4042209b26ba6d001f94b6b5f09bc9d6d337
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
28716
x-xss-protection
0
server
cafe
etag
831 / 19779 / m202402200101 / config-hash: 8786292873359934690
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
expires
Mon, 26 Feb 2024 17:20:37 GMT
launch-d12cb4e80409.min.js
assets.adobedtm.com/eb2e22881c4a/eca1b21caf50/
372 KB
103 KB
Script
General
Full URL
https://assets.adobedtm.com/eb2e22881c4a/eca1b21caf50/launch-d12cb4e80409.min.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:480:7a5::1e80 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
176fdac4f22c8cf1c05ccc1e93f17fda46e356f4a3d1a3eb45d825ff7a651f55

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
last-modified
Fri, 23 Feb 2024 15:00:49 GMT
server
AkamaiNetStorage
etag
"3b2e0ae8d8628fb1b0eeed3f586aa62f:1708700449.472962"
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
max-age=3600
accept-ranges
bytes
timing-allow-origin
*
content-length
105612
expires
Mon, 26 Feb 2024 18:20:37 GMT
bpr.png
www.biopharma-reporter.com/content/download/3061/logo_prestitial/
Redirect Chain
  • https://www.biopharma-reporter.com/content/download/3061/9283809?version=11
  • https://www.biopharma-reporter.com/content/download/3061/logo_prestitial/bpr.png?version=11
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/content/download/3061/logo_prestitial/bpr.png?version=11
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
d70255b8c828c9a1dd23facaa933f0bc31e1ac70cc916bd02085fbec19b98184
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 31 Jan 2023 08:36:22 GMT
age
362372
traceresponse
00-17b62fccb124b975faaec15d08818da0-fb0ceae4fcd1f07a-01
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=86400, private, stale-while-revalidate=3600
content-transfer-encoding
binary
content-disposition
attachment; filename="bpr.png"
accept-ranges
bytes
content-length
4003
x-xss-protection
1; mode=block

Redirect headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
age
2690
traceresponse
00-17b776ede2362dbc33ed3111e8f4bbbe-9678a1599b338773-01
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
/content/download/3061/logo_prestitial/bpr.png?version=11
cache-control
public
accept-ranges
bytes
content-length
474
x-xss-protection
1; mode=block
bpr-logo.svg
www.biopharma-reporter.com/content/download/3061/logo/
Redirect Chain
  • https://www.biopharma-reporter.com/content/download/3061/18689?version=11
  • https://www.biopharma-reporter.com/content/download/3061/logo/bpr-logo.svg?version=11
9 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/content/download/3061/logo/bpr-logo.svg?version=11
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
771edd8dd97f13774327413c71f27b047657229dd99d3dc9d5297c4f251dc518
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
date
Mon, 26 Feb 2024 17:20:37 GMT
age
326509
traceresponse
00-17b6506ad5f97031af88c9d6378bc99c-f22790a85842f186-01
content-transfer-encoding
binary
content-disposition
attachment; filename="bpr-logo.svg"
content-length
3450
x-xss-protection
1; mode=block
last-modified
Tue, 31 Jan 2023 08:36:22 GMT
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=86400, private, stale-while-revalidate=3600
accept-ranges
bytes

Redirect headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
age
2690
traceresponse
00-17b776ede3082562c78e4709a7e68aac-c052955869c60348-01
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
/content/download/3061/logo/bpr-logo.svg?version=11
cache-control
public
accept-ranges
bytes
content-length
450
x-xss-protection
1; mode=block
bpr-logo.svg
www.biopharma-reporter.com/content/download/3061/logo_mobile/
Redirect Chain
  • https://www.biopharma-reporter.com/content/download/3061/4362127?version=11
  • https://www.biopharma-reporter.com/content/download/3061/logo_mobile/bpr-logo.svg?version=11
9 KB
3 KB
Image
General
Full URL
https://www.biopharma-reporter.com/content/download/3061/logo_mobile/bpr-logo.svg?version=11
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
771edd8dd97f13774327413c71f27b047657229dd99d3dc9d5297c4f251dc518
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
date
Mon, 26 Feb 2024 17:20:37 GMT
age
362372
traceresponse
00-17b62fcccd7ad5364a9b6d0e9d9e94a1-d6742c868dcfa82f-01
content-transfer-encoding
binary
content-disposition
attachment; filename="bpr-logo.svg"
content-length
3450
x-xss-protection
1; mode=block
last-modified
Tue, 31 Jan 2023 08:36:22 GMT
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=86400, private, stale-while-revalidate=3600
accept-ranges
bytes

Redirect headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
age
2690
traceresponse
00-17b776ede33963c16f576a9d0b0508d1-d4fcb9fdf29389a5-01
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
/content/download/3061/logo_mobile/bpr-logo.svg?version=11
cache-control
public
accept-ranges
bytes
content-length
478
x-xss-protection
1; mode=block
3649966f-cab2-4eb8-af76-2efa9af8e3a7.json
cdn.cookielaw.org/consent/3649966f-cab2-4eb8-af76-2efa9af8e3a7/
4 KB
2 KB
XHR
General
Full URL
https://cdn.cookielaw.org/consent/3649966f-cab2-4eb8-af76-2efa9af8e3a7/3649966f-cab2-4eb8-af76-2efa9af8e3a7.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b5f6850021edc42c5ba84998b184230cd4a624b7de85a0f5f4553d333c55a04f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
strict-transport-security
max-age=31536000; includeSubDomains; preload
age
43764
content-md5
iKcejjSPd95xDfe7INXc4g==
content-length
1677
x-ms-lease-status
unlocked
last-modified
Mon, 12 Feb 2024 10:46:17 GMT
server
cloudflare
etag
0x8DC2BB7D79012E0
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
*
x-ms-request-id
e5414fcc-301e-0034-47a0-5d0a4b000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1c3ad95d50-FRA
expires
Tue, 27 Feb 2024 17:20:37 GMT
gtm.js
www.googletagmanager.com/
231 KB
78 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-PBQBMR
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
e030670aa1e48b007d30ac09fa5a932bdd18bf17c836dabbd5ff01524c86cc74
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79731
x-xss-protection
0
last-modified
Mon, 26 Feb 2024 16:43:27 GMT
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Mon, 26 Feb 2024 17:20:37 GMT
load
experience.tinypass.com/xbuilder/experience/
4 KB
1 KB
Script
General
Full URL
https://experience.tinypass.com/xbuilder/experience/load?aid=1f6nyjoJpu
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:907e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f6e65a2c764ffe340d94d75b3a4c4aa2ea360817e6c3ef289dd22f5e638632d2
Security Headers
Name Value
Strict-Transport-Security max-age=86400; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
date
Mon, 26 Feb 2024 17:20:37 GMT
strict-transport-security
max-age=86400; includeSubDomains
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 26 Feb 2024 16:24:58 GMT
server
cloudflare
age
3339
vary
Accept-Encoding, Origin
content-type
application/javascript; charset=UTF-8
cache-control
public, max-age=1800
cf-ray
85b9dc1c6a4abbc2-FRA
alt-svc
h3=":443"; ma=86400
x-request-id
cz7ngoiutv
expires
Mon, 26 Feb 2024 17:50:37 GMT
icons.svg
www.biopharma-reporter.com/bundles/wrbmgbfront/sprite/
59 KB
17 KB
Other
General
Full URL
https://www.biopharma-reporter.com/bundles/wrbmgbfront/sprite/icons.svg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
4dbc48684899eeb325b58da46eef44fa80df6dc42c62238319a51d938f76ee75
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 06 Feb 2024 07:28:24 GMT
age
386766
traceresponse
00-17b5c63bc615c973e0189add734de7ef-220ec4400b627fe6-01
etag
W/"65c1df98-ebd3"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=7200
accept-ranges
bytes
content-length
17074
expires
Wed, 21 Feb 2024 06:26:33 GMT
Novo-Nordisk-and-Catalent-deal-net-positive-or-negative-for-industry.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/20/novo-nordisk-and-catalent-deal-ne...
28 KB
28 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/20/novo-nordisk-and-catalent-deal-net-positive-or-negative-for-industry/17184125-1-eng-GB/Novo-Nordisk-and-Catalent-deal-net-positive-or-negative-for-industry.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
dc26f4a4bc76648888d162dcee045a094bb1721c338054bdcb29f71acfb2e327
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 11:49:33 GMT
age
362372
traceresponse
00-17b62fccd69febc38d4d9e3c74707425-1d7861ed74dd659c-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
28412
x-xss-protection
1; mode=block
Janssen-s-CAR-T-multiple-myeloma-therapy-gets-greenlight-from-EMA.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/janssen-s-car-t-multiple-...
10 KB
10 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/janssen-s-car-t-multiple-myeloma-therapy-gets-greenlight-from-ema/17203226-1-eng-GB/Janssen-s-CAR-T-multiple-myeloma-therapy-gets-greenlight-from-EMA.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
52a93a8ad0e18d8476ceb9413aca863b3f33603eb93095730c48315834e0b739
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 26 Feb 2024 12:51:31 GMT
age
13659
traceresponse
00-17b76cf3e4b82c142c65219c4a5b400d-30b329d33e442a08-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
9736
x-xss-protection
1; mode=block
Voluntary-pause-of-epetraborole-phase-3-enrollment-setback-for-NTM-pipeline.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/voluntary-pause-of-epetra...
12 KB
12 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/voluntary-pause-of-epetraborole-phase-3-enrollment-setback-for-ntm-pipeline/17201597-1-eng-GB/Voluntary-pause-of-epetraborole-phase-3-enrollment-setback-for-NTM-pipeline.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
13428e447629102ec4cc07ba2a6af0d846282cf41e023a5340f36c7e2f2e6962
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 26 Feb 2024 12:53:43 GMT
age
13659
traceresponse
00-17b76cf3e3dbc02af30f6d8861fb7121-347511360d25c3be-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
12484
x-xss-protection
1; mode=block
Neuraxpharm-launches-new-multiple-sclerosis-treatment-in-Europe.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/neuraxpharm-launches-new-...
13 KB
13 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/neuraxpharm-launches-new-multiple-sclerosis-treatment-in-europe/17203334-1-eng-GB/Neuraxpharm-launches-new-multiple-sclerosis-treatment-in-Europe.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
27d77cc1434a49f2264221a4795fb15058d4fb7f5ca26987304d8f3744a781ed
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 26 Feb 2024 12:51:31 GMT
age
13659
traceresponse
00-17b76cf3e23c0a68aaa03526e15ae6b6-49f8fb22e156aefe-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
13579
x-xss-protection
1; mode=block
Biora-s-BT-600-novel-drug-device-may-revolutionise-targeted-colon-therapy.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/biora-s-bt-600-novel-d...
7 KB
7 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_small/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/biora-s-bt-600-novel-drug-device-may-revolutionise-targeted-colon-therapy/17189054-1-eng-GB/Biora-s-BT-600-novel-drug-device-may-revolutionise-targeted-colon-therapy.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
2ae6a459debb67ba63ec08dbabc898e69c85d53dc8bc1aee98a35d2e7960f3b4
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 26 Feb 2024 12:51:31 GMT
age
13659
traceresponse
00-17b76cf3e237075e4898ab191815b17b-a078eecb3acdd4ee-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
7198
x-xss-protection
1; mode=block
bpr.png
www.biopharma-reporter.com/content/download/3061/logo_prestitial/
Redirect Chain
  • https://www.biopharma-reporter.com/content/download/3061/9283809?version=11
  • https://www.biopharma-reporter.com/content/download/3061/logo_prestitial/bpr.png?version=11
4 KB
4 KB
Other
General
Full URL
https://www.biopharma-reporter.com/content/download/3061/logo_prestitial/bpr.png?version=11
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
d70255b8c828c9a1dd23facaa933f0bc31e1ac70cc916bd02085fbec19b98184
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 31 Jan 2023 08:36:22 GMT
age
362372
traceresponse
00-17b62fccb124b975faaec15d08818da0-fb0ceae4fcd1f07a-01
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=86400, private, stale-while-revalidate=3600
content-transfer-encoding
binary
content-disposition
attachment; filename="bpr.png"
accept-ranges
bytes
content-length
4003
x-xss-protection
1; mode=block

Redirect headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
age
2690
traceresponse
00-17b776ede2362dbc33ed3111e8f4bbbe-9678a1599b338773-01
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
/content/download/3061/logo_prestitial/bpr.png?version=11
cache-control
public
accept-ranges
bytes
content-length
474
x-xss-protection
1; mode=block
bpr-logo.svg
www.biopharma-reporter.com/content/download/3061/logo/
Redirect Chain
  • https://www.biopharma-reporter.com/content/download/3061/18689?version=11
  • https://www.biopharma-reporter.com/content/download/3061/logo/bpr-logo.svg?version=11
9 KB
3 KB
Other
General
Full URL
https://www.biopharma-reporter.com/content/download/3061/logo/bpr-logo.svg?version=11
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
771edd8dd97f13774327413c71f27b047657229dd99d3dc9d5297c4f251dc518
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
date
Mon, 26 Feb 2024 17:20:37 GMT
age
326509
traceresponse
00-17b6506ad5f97031af88c9d6378bc99c-f22790a85842f186-01
content-transfer-encoding
binary
content-disposition
attachment; filename="bpr-logo.svg"
content-length
3450
x-xss-protection
1; mode=block
last-modified
Tue, 31 Jan 2023 08:36:22 GMT
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=86400, private, stale-while-revalidate=3600
accept-ranges
bytes

Redirect headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
age
2690
traceresponse
00-17b776ede3082562c78e4709a7e68aac-c052955869c60348-01
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
/content/download/3061/logo/bpr-logo.svg?version=11
cache-control
public
accept-ranges
bytes
content-length
450
x-xss-protection
1; mode=block
uMotif-and-MoCA-collaborate-to-deepen-commitment-to-CNS-research.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/02/26/umotif-and-moca-collaborate-to-d...
11 KB
11 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/02/26/umotif-and-moca-collaborate-to-deepen-commitment-to-cns-research/17201972-1-eng-GB/uMotif-and-MoCA-collaborate-to-deepen-commitment-to-CNS-research.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
dcace80029444875e3d2416033442b3c5f8bd1268370c7330a319fafcdde6448
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 26 Feb 2024 13:04:02 GMT
age
13659
traceresponse
00-17b76cf3e4af867ee7703d9407719c26-b30088d1b3ee45f0-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
10955
x-xss-protection
1; mode=block
IQVIA-s-director-of-AI-engineering-on-training-machines-to-speed-up-trials.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/02/23/iqvia-s-director-of-ai-engineeri...
10 KB
10 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/02/23/iqvia-s-director-of-ai-engineering-on-training-machines-to-speed-up-trials/17196173-1-eng-GB/IQVIA-s-director-of-AI-engineering-on-training-machines-to-speed-up-trials.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
38f999394c19dde0dab8dc01c206aa37393943ed2f4045b8e70beebd7c329cf3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Fri, 23 Feb 2024 11:33:06 GMT
age
249602
traceresponse
00-17b6965d1dd5c3830b994cf3873a67ae-01454816d0c705f2-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
10246
x-xss-protection
1; mode=block
From-Principal-IRB-to-Univo-a-conversation-with-Julie-Blasingim.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/from-principal-irb-to...
10 KB
10 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/from-principal-irb-to-univo-a-conversation-with-julie-blasingim/17190398-1-eng-GB/From-Principal-IRB-to-Univo-a-conversation-with-Julie-Blasingim.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
4eda2dc3978ba6b279881a236cc1cfbb38faa250b7d2838bc7f4ab012dbd5607
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Wed, 21 Feb 2024 16:36:52 GMT
age
281865
traceresponse
00-17b679053652333a5d0546bef0a99306-c1ca7e39aedf6a23-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
9869
x-xss-protection
1; mode=block
NICE-guidance-recommends-GSK-s-Omjjara-as-treatment-option.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/headlines/clinical-development/nice-guidance-recomm...
8 KB
8 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/headlines/clinical-development/nice-guidance-recommends-gsk-s-omjjara-as-treatment-option/17193047-1-eng-GB/NICE-guidance-recommends-GSK-s-Omjjara-as-treatment-option.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
d2e4dcd40a902d0d4e436c2f8b40b6ab14a6aa8f0a4de3a96cc5a849f87ec92d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 22 Feb 2024 12:35:28 GMT
age
291088
traceresponse
00-17b670a20892c2477e85c62124d61ef1-1f7220804b1ada20-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
7795
x-xss-protection
1; mode=block
Bristol-Myers-Squibb-invests-over-400m-in-sterile-drug-product-facility.png
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/bristol-myers-squibb-...
416 KB
416 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/bristol-myers-squibb-invests-over-400m-in-sterile-drug-product-facility/17192993-1-eng-GB/Bristol-Myers-Squibb-invests-over-400m-in-sterile-drug-product-facility.png
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
b7694f63c5af45a1b0db228397108741a6094c2cd180c26f119f8a809e592d77
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 22 Feb 2024 12:25:47 GMT
age
361985
traceresponse
00-17b63026fe405a02ea43c5a0723d4dd3-5d0a4430f34dff16-01
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
425563
x-xss-protection
1; mode=block
MIP-Discovery-raises-7m-to-drive-commercialization-in-cell-and-gene-space.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/22/mip-discovery-raises-7m-to-drive...
31 KB
32 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/22/mip-discovery-raises-7m-to-drive-commercialization-in-cell-and-gene-space/17189225-1-eng-GB/MIP-Discovery-raises-7m-to-drive-commercialization-in-cell-and-gene-space.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
46c89933539017dacc1c9b287849c888fea59b03b7c56c4140cc2920a15c2080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 22 Feb 2024 12:30:46 GMT
age
35189
traceresponse
00-17b7595f1c279f6d486597f9c12b8d2e-a64ffa803f8f3655-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
32243
x-xss-protection
1; mode=block
AstraZeneca-s-DKD-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/astrazeneca-s-dkd-pip...
17 KB
17 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/astrazeneca-s-dkd-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space/17182556-1-eng-GB/AstraZeneca-s-DKD-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
a591df7e4b29b25a7aca733c5f460f188fbd31a63ca4ad7332f7873d79958e44
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 11:44:57 GMT
age
351696
traceresponse
00-17b639827eb5ff887952e2af8dfecfef-3b5d39288430ca33-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
16936
x-xss-protection
1; mode=block
QBIOTICs-drug-awarded-Orphan-Drug-Designation-for-patients-with-soft-tissue-sarcoma.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/qbiotics-drug-awarded-or...
23 KB
23 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/qbiotics-drug-awarded-orphan-drug-designation-for-patients-with-soft-tissue-sarcoma/17182394-1-eng-GB/QBIOTICs-drug-awarded-Orphan-Drug-Designation-for-patients-with-soft-tissue-sarcoma.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
782b9c4ed9f284c33a97b03254a22b61b54e83c1143f51f72beab4e1c571ae8e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 11:39:12 GMT
age
222647
traceresponse
00-17b6aee113e8518b99b8db6fb78ba6c5-07ddc5d72609c7cb-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
23532
x-xss-protection
1; mode=block
Innovative-Trials-partners-with-Oliver-Patch-Project-for-trial-retention.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/innovative-trials-par...
26 KB
26 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/innovative-trials-partners-with-oliver-patch-project-for-trial-retention/17182178-1-eng-GB/Innovative-Trials-partners-with-Oliver-Patch-Project-for-trial-retention.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
bf1c68edb9dc2091f9f8c6a77eceeae6d47a891a55bd70e6d27fd0f787bb8813
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 19 Feb 2024 16:04:42 GMT
age
359383
traceresponse
00-17b63284c124d3feedf57b76572aaef6-7a6dd0692e48e1f8-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
26759
x-xss-protection
1; mode=block
Gilead-Sciences-strengthens-commitment-to-inflammatory-disease-with-new-research-site.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/19/gilead-sciences-strengthens-comm...
34 KB
34 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/19/gilead-sciences-strengthens-commitment-to-inflammatory-disease-with-new-research-site/17179004-1-eng-GB/Gilead-Sciences-strengthens-commitment-to-inflammatory-disease-with-new-research-site.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
5d5bda5f25790c151bb88185495e529708f6db7caddbc57a918fff266790e635
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 19 Feb 2024 10:58:28 GMT
age
342886
traceresponse
00-17b64185ea1cd1880c3fe4bd5ff44f26-663c6b8875752a49-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
34617
x-xss-protection
1; mode=block
WATCH-Cell-and-gene-therapy-manufacturing-panel-at-Advanced-Therapies-Week-2024.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/05/watch-cell-and-gene-therapy-manufa...
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/05/watch-cell-and-gene-therapy-manufacturing-panel-at-advanced-therapies-week-2024/17138717-1-eng-GB/WATCH-Cell-and-gene-therapy-manufacturing-panel-at-Advanced-Therapies-Week-2024.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
56c5b0819d8610593b31da259eb5759a57b75396ed5956a5ca27dd444e993d68
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 05 Feb 2024 11:33:51 GMT
age
301721
traceresponse
00-17b666f64f1e06741a077840a3bc8899-9ee377f4fb901b47-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
3852
x-xss-protection
1; mode=block
Beyond-chemotherapy-Navigating-the-promise-and-perils-of-CAR-T-therapy-in-pediatric-cancer.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/01/beyond-chemotherapy-navigating-the...
5 KB
5 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/01/beyond-chemotherapy-navigating-the-promise-and-perils-of-car-t-therapy-in-pediatric-cancer/17132672-1-eng-GB/Beyond-chemotherapy-Navigating-the-promise-and-perils-of-CAR-T-therapy-in-pediatric-cancer.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
a0c466313284b1ef8a7490eb2166046dd687cbd11a7409a33b51c2430453a2c9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 01 Feb 2024 13:55:10 GMT
age
342886
traceresponse
00-17b64185e8e87ff35585a8fec4c90808-1bce3a747ac6cdbc-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
4952
x-xss-protection
1; mode=block
US-Department-of-Defense-funds-MediWound-s-non-surgical-burn-treatment.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/us-department-of-defense-f...
5 KB
5 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/us-department-of-defense-funds-mediwound-s-non-surgical-burn-treatment/17043224-1-eng-GB/US-Department-of-Defense-funds-MediWound-s-non-surgical-burn-treatment.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
024e20c497cfd87ac2d132ef93c42573402c19456480f114cc0f7830e3b9f121
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 02 Jan 2024 11:32:01 GMT
age
222649
traceresponse
00-17b6aee0ae7d65b85b155c00a5e6720d-e39b9d21088be7ca-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
5112
x-xss-protection
1; mode=block
The-top-5-ADC-startups-favoured-by-venture-capital-investors.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/the-top-5-adc-startups-...
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/the-top-5-adc-startups-favoured-by-venture-capital-investors/17034786-1-eng-GB/The-top-5-ADC-startups-favoured-by-venture-capital-investors.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
19271b2228a30874a4eaa9a4e886d0fb3f6f3c6b9d00c347c4a376a980385535
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 21 Dec 2023 12:55:08 GMT
age
222649
traceresponse
00-17b6aee0ac06cc5bee2be504b7094a82-8f5306797c050bfd-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
4280
x-xss-protection
1; mode=block
Podcast-The-British-start-up-taking-psychedelic-therapy-mainstream.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/10/16/podcast-the-british-start-up-takin...
2 KB
2 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/10/16/podcast-the-british-start-up-taking-psychedelic-therapy-mainstream/16842411-1-eng-GB/Podcast-The-British-start-up-taking-psychedelic-therapy-mainstream.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
10d2fb49b134e35afbb3e84842709f49e7090d276bab57b2d9f5cd09168802a6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 19 Oct 2023 09:39:32 GMT
age
342886
traceresponse
00-17b64185e9e1a36e64022c6b4faf1ca8-e93968dce67ca7ea-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
2221
x-xss-protection
1; mode=block
Psychoactive-drug-methylone-tested-as-new-PSTD-treatment-in-London-trial.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/psychoactive-drug-methylon...
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/psychoactive-drug-methylone-tested-as-new-pstd-treatment-in-london-trial/16856844-1-eng-GB/Psychoactive-drug-methylone-tested-as-new-PSTD-treatment-in-London-trial.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0d046d75662fc752968c695d2bef2cd8b4f85c4601487127501c2209926f33e8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 19 Oct 2023 11:31:16 GMT
age
301721
traceresponse
00-17b666f6518c820814bafa37bb46dc5d-239e6e0f5be867fb-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
3739
x-xss-protection
1; mode=block
e3f07a2.js
www.biopharma-reporter.com/js/
254 KB
73 KB
Script
General
Full URL
https://www.biopharma-reporter.com/js/e3f07a2.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
e07246b798ecdab8699574e9282b4ad1fc9f941901b49de7b4270379520ee416
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 06 Feb 2024 07:28:48 GMT
age
283754
traceresponse
00-17b5bc125408b6a309a6a9685d22f54f-51becabb471f9f33-01
etag
W/"65c1dfb0-3f7e9"
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=7200
accept-ranges
bytes
content-length
74762
expires
Wed, 21 Feb 2024 03:20:20 GMT
api.js
www.google.com/recaptcha/
1 KB
1 KB
Script
General
Full URL
https://www.google.com/recaptcha/api.js?hl=en-GB
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
GSE /
Resource Hash
5c49b44115a0f2fbce7265619a49be97f7f320a9efea378374ccfe5b0b0d3cb3
Security Headers
Name Value
Content-Security-Policy frame-ancestors 'self'
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy
frame-ancestors 'self'
server
GSE
x-frame-options
SAMEORIGIN
content-type
text/javascript; charset=utf-8
cache-control
private, max-age=300
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
1; mode=block
expires
Mon, 26 Feb 2024 17:20:37 GMT
hx4BqjQX.js
cdn.jwplayer.com/libraries/
110 KB
41 KB
Script
General
Full URL
https://cdn.jwplayer.com/libraries/hx4BqjQX.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2600:9000:225e:c800:1:a3fa:7cc0:93a1 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
Software
openresty /
Resource Hash
00cfb584364b62c637a74612eaaeebe1d97e0362178bbdf811b8534026a65b8d

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:18:08 GMT
content-encoding
gzip
via
1.1 ed7f977b6d983a16331e3fe3f4764e9a.cloudfront.net (CloudFront)
server
openresty
x-amz-cf-pop
FRA60-P4
age
149
x-cache
Hit from cloudfront
content-type
text/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=180
x-robots-tag
noindex, indexifembedded
content-length
42018
x-amz-cf-id
_lvK7ZelmK5LFxxjw7IgwzXLzoXYa0aj5KrBxh6r5Tpm3UUKBGf_4Q==
wrbm-footer.js
footer.wrbm.com/Footers/
12 KB
4 KB
Script
General
Full URL
https://footer.wrbm.com/Footers/wrbm-footer.js?lan=en&ent=WRBM
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.184.21 Kansas City, United States, ASN396982 (GOOGLE-CLOUD-PLATFORM, US),
Reverse DNS
21.184.107.34.bc.googleusercontent.com
Software
Apache/2.4.56 (Debian) /
Resource Hash
234beb13c11bb6f2d9bb856a72b956dac060f78752f929277a61024e5758e1e7
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubdomains;
X-Content-Type-Options nosniff
X-Frame-Options sameorigin
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=63072000; includeSubdomains;
via
1.1 google
server
Apache/2.4.56 (Debian)
vary
Accept-Encoding
x-frame-options
sameorigin
content-type
text/javascript; charset=UTF-8
cache-control
max-age=0, must-revalidate, private, s-maxage=31536000
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
3547
x-xss-protection
1; mode=block
expires
Mon, 26 Feb 2024 17:20:37 GMT
truncated
/
197 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
67ccf62c6528e9d4642d7012ef472b0175b68abfbb4c494851b9b98a68948403

Request headers

accept-language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

Content-Type
image/svg+xml
UcC73FwrK3iLTeHuS_fvQtMwCp50KnMa1ZL7.woff2
fonts.gstatic.com/s/inter/v13/
46 KB
46 KB
Font
General
Full URL
https://fonts.gstatic.com/s/inter/v13/UcC73FwrK3iLTeHuS_fvQtMwCp50KnMa1ZL7.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:810::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88df0b5a7bc397dbc13a26bb8b3742cc62cd1c9b0dded57da7832416d6f52f42
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.biopharma-reporter.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Sun, 25 Feb 2024 03:13:55 GMT
x-content-type-options
nosniff
age
137202
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
46704
x-xss-protection
0
last-modified
Wed, 13 Sep 2023 23:49:07 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 24 Feb 2025 03:13:55 GMT
location
geolocation.onetrust.com/cookieconsentpub/v1/geo/
68 B
315 B
XHR
General
Full URL
https://geolocation.onetrust.com/cookieconsentpub/v1/geo/location
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:4400::ac40:9b77 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e9433f83f20500145850d5aabddced402dcfc94e310072e9a3f545df0bdb9f96
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload

Request headers

accept
application/json
Referer
https://www.biopharma-reporter.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-encoding
gzip
server
cloudflare
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS
content-type
application/json
access-control-allow-origin
*
cf-ray
85b9dc1d2a7618c7-FRA
access-control-allow-headers
Content-Type
Novo-Nordisk-and-Catalent-deal-net-positive-or-negative-for-industry.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/20/novo-nordisk-and-catalent-deal-ne...
28 KB
28 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/20/novo-nordisk-and-catalent-deal-net-positive-or-negative-for-industry/17184125-1-eng-GB/Novo-Nordisk-and-Catalent-deal-net-positive-or-negative-for-industry.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
dc26f4a4bc76648888d162dcee045a094bb1721c338054bdcb29f71acfb2e327
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 11:49:33 GMT
age
362372
traceresponse
00-17b62fccd69febc38d4d9e3c74707425-1d7861ed74dd659c-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
28412
x-xss-protection
1; mode=block
IQVIA-s-director-of-AI-engineering-on-training-machines-to-speed-up-trials.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/02/23/iqvia-s-director-of-ai-engineeri...
10 KB
10 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/article/2024/02/23/iqvia-s-director-of-ai-engineering-on-training-machines-to-speed-up-trials/17196173-1-eng-GB/IQVIA-s-director-of-AI-engineering-on-training-machines-to-speed-up-trials.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
38f999394c19dde0dab8dc01c206aa37393943ed2f4045b8e70beebd7c329cf3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Fri, 23 Feb 2024 11:33:06 GMT
age
249602
traceresponse
00-17b6965d1dd5c3830b994cf3873a67ae-01454816d0c705f2-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
10246
x-xss-protection
1; mode=block
From-Principal-IRB-to-Univo-a-conversation-with-Julie-Blasingim.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/from-principal-irb-to...
10 KB
10 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/from-principal-irb-to-univo-a-conversation-with-julie-blasingim/17190398-1-eng-GB/From-Principal-IRB-to-Univo-a-conversation-with-Julie-Blasingim.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
4eda2dc3978ba6b279881a236cc1cfbb38faa250b7d2838bc7f4ab012dbd5607
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Wed, 21 Feb 2024 16:36:52 GMT
age
281865
traceresponse
00-17b679053652333a5d0546bef0a99306-c1ca7e39aedf6a23-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
9869
x-xss-protection
1; mode=block
NICE-guidance-recommends-GSK-s-Omjjara-as-treatment-option.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/headlines/clinical-development/nice-guidance-recomm...
8 KB
8 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser/publications/pharmaceutical-science/outsourcing-pharma.com/headlines/clinical-development/nice-guidance-recommends-gsk-s-omjjara-as-treatment-option/17193047-1-eng-GB/NICE-guidance-recommends-GSK-s-Omjjara-as-treatment-option.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
d2e4dcd40a902d0d4e436c2f8b40b6ab14a6aa8f0a4de3a96cc5a849f87ec92d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 22 Feb 2024 12:35:28 GMT
age
291088
traceresponse
00-17b670a20892c2477e85c62124d61ef1-1f7220804b1ada20-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
7795
x-xss-protection
1; mode=block
Bristol-Myers-Squibb-invests-over-400m-in-sterile-drug-product-facility.png
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/bristol-myers-squibb-...
416 KB
416 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/bristol-myers-squibb-invests-over-400m-in-sterile-drug-product-facility/17192993-1-eng-GB/Bristol-Myers-Squibb-invests-over-400m-in-sterile-drug-product-facility.png
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
b7694f63c5af45a1b0db228397108741a6094c2cd180c26f119f8a809e592d77
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 22 Feb 2024 12:25:47 GMT
age
361985
traceresponse
00-17b63026fe405a02ea43c5a0723d4dd3-5d0a4430f34dff16-01
x-frame-options
SAMEORIGIN
content-type
image/png
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
425563
x-xss-protection
1; mode=block
AstraZeneca-s-DKD-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/astrazeneca-s-dkd-pip...
17 KB
17 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/astrazeneca-s-dkd-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space/17182556-1-eng-GB/AstraZeneca-s-DKD-pipeline-highlights-potential-to-differentiate-in-kidney-disease-space.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
a591df7e4b29b25a7aca733c5f460f188fbd31a63ca4ad7332f7873d79958e44
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 11:44:57 GMT
age
351697
traceresponse
00-17b639827eb5ff887952e2af8dfecfef-3b5d39288430ca33-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
16936
x-xss-protection
1; mode=block
QBIOTICs-drug-awarded-Orphan-Drug-Designation-for-patients-with-soft-tissue-sarcoma.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/qbiotics-drug-awarded-or...
23 KB
23 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/qbiotics-drug-awarded-orphan-drug-designation-for-patients-with-soft-tissue-sarcoma/17182394-1-eng-GB/QBIOTICs-drug-awarded-Orphan-Drug-Designation-for-patients-with-soft-tissue-sarcoma.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
782b9c4ed9f284c33a97b03254a22b61b54e83c1143f51f72beab4e1c571ae8e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 11:39:12 GMT
age
222647
traceresponse
00-17b6aee113e8518b99b8db6fb78ba6c5-07ddc5d72609c7cb-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
23532
x-xss-protection
1; mode=block
Innovative-Trials-partners-with-Oliver-Patch-Project-for-trial-retention.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/innovative-trials-par...
26 KB
26 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/outsourcing-pharma.com/hot-topics/patient-centricity/innovative-trials-partners-with-oliver-patch-project-for-trial-retention/17182178-1-eng-GB/Innovative-Trials-partners-with-Oliver-Patch-Project-for-trial-retention.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
bf1c68edb9dc2091f9f8c6a77eceeae6d47a891a55bd70e6d27fd0f787bb8813
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 19 Feb 2024 16:04:42 GMT
age
359383
traceresponse
00-17b63284c124d3feedf57b76572aaef6-7a6dd0692e48e1f8-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
26759
x-xss-protection
1; mode=block
Gilead-Sciences-strengthens-commitment-to-inflammatory-disease-with-new-research-site.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/19/gilead-sciences-strengthens-comm...
34 KB
34 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_medium/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/19/gilead-sciences-strengthens-commitment-to-inflammatory-disease-with-new-research-site/17179004-1-eng-GB/Gilead-Sciences-strengthens-commitment-to-inflammatory-disease-with-new-research-site.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
5d5bda5f25790c151bb88185495e529708f6db7caddbc57a918fff266790e635
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 19 Feb 2024 10:58:28 GMT
age
342886
traceresponse
00-17b64185ea1cd1880c3fe4bd5ff44f26-663c6b8875752a49-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
34617
x-xss-protection
1; mode=block
WATCH-Cell-and-gene-therapy-manufacturing-panel-at-Advanced-Therapies-Week-2024.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/05/watch-cell-and-gene-therapy-manufa...
4 KB
4 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/05/watch-cell-and-gene-therapy-manufacturing-panel-at-advanced-therapies-week-2024/17138717-1-eng-GB/WATCH-Cell-and-gene-therapy-manufacturing-panel-at-Advanced-Therapies-Week-2024.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
56c5b0819d8610593b31da259eb5759a57b75396ed5956a5ca27dd444e993d68
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 05 Feb 2024 11:33:51 GMT
age
301721
traceresponse
00-17b666f64f1e06741a077840a3bc8899-9ee377f4fb901b47-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
3852
x-xss-protection
1; mode=block
Beyond-chemotherapy-Navigating-the-promise-and-perils-of-CAR-T-therapy-in-pediatric-cancer.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/01/beyond-chemotherapy-navigating-the...
5 KB
5 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/01/beyond-chemotherapy-navigating-the-promise-and-perils-of-car-t-therapy-in-pediatric-cancer/17132672-1-eng-GB/Beyond-chemotherapy-Navigating-the-promise-and-perils-of-CAR-T-therapy-in-pediatric-cancer.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
a0c466313284b1ef8a7490eb2166046dd687cbd11a7409a33b51c2430453a2c9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 01 Feb 2024 13:55:10 GMT
age
342886
traceresponse
00-17b64185e8e87ff35585a8fec4c90808-1bce3a747ac6cdbc-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
4952
x-xss-protection
1; mode=block
US-Department-of-Defense-funds-MediWound-s-non-surgical-burn-treatment.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/us-department-of-defense-f...
5 KB
5 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/us-department-of-defense-funds-mediwound-s-non-surgical-burn-treatment/17043224-1-eng-GB/US-Department-of-Defense-funds-MediWound-s-non-surgical-burn-treatment.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
024e20c497cfd87ac2d132ef93c42573402c19456480f114cc0f7830e3b9f121
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 02 Jan 2024 11:32:01 GMT
age
222649
traceresponse
00-17b6aee0ae7d65b85b155c00a5e6720d-e39b9d21088be7ca-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
5112
x-xss-protection
1; mode=block
The-top-5-ADC-startups-favoured-by-venture-capital-investors.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/the-top-5-adc-startups-...
4 KB
4 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/the-top-5-adc-startups-favoured-by-venture-capital-investors/17034786-1-eng-GB/The-top-5-ADC-startups-favoured-by-venture-capital-investors.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
19271b2228a30874a4eaa9a4e886d0fb3f6f3c6b9d00c347c4a376a980385535
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 21 Dec 2023 12:55:08 GMT
age
222649
traceresponse
00-17b6aee0ac06cc5bee2be504b7094a82-8f5306797c050bfd-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
4280
x-xss-protection
1; mode=block
Podcast-The-British-start-up-taking-psychedelic-therapy-mainstream.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/10/16/podcast-the-british-start-up-takin...
2 KB
2 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/10/16/podcast-the-british-start-up-taking-psychedelic-therapy-mainstream/16842411-1-eng-GB/Podcast-The-British-start-up-taking-psychedelic-therapy-mainstream.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
10d2fb49b134e35afbb3e84842709f49e7090d276bab57b2d9f5cd09168802a6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 19 Oct 2023 09:39:32 GMT
age
342886
traceresponse
00-17b64185e9e1a36e64022c6b4faf1ca8-e93968dce67ca7ea-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
2221
x-xss-protection
1; mode=block
Psychoactive-drug-methylone-tested-as-new-PSTD-treatment-in-London-trial.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/psychoactive-drug-methylon...
4 KB
4 KB
Other
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/psychoactive-drug-methylone-tested-as-new-pstd-treatment-in-london-trial/16856844-1-eng-GB/Psychoactive-drug-methylone-tested-as-new-PSTD-treatment-in-London-trial.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0d046d75662fc752968c695d2bef2cd8b4f85c4601487127501c2209926f33e8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 19 Oct 2023 11:31:16 GMT
age
301721
traceresponse
00-17b666f6518c820814bafa37bb46dc5d-239e6e0f5be867fb-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
3739
x-xss-protection
1; mode=block
tinypass.min.js
cdn.tinypass.com/api/
390 KB
115 KB
Script
General
Full URL
https://cdn.tinypass.com/api/tinypass.min.js
Requested by
Host: experience.tinypass.com
URL: https://experience.tinypass.com/xbuilder/experience/load?aid=1f6nyjoJpu
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:907e , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
97ed4d32ee64f03547251736eca1b942da433d76a677f13e47881214ec760e7e
Security Headers
Name Value
Strict-Transport-Security max-age=86400; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:37 GMT
x-amz-version-id
sYJR8dcenTNZeMU2Zzi1.tz6VDkdunuC
content-encoding
br
cf-cache-status
HIT
strict-transport-security
max-age=86400; includeSubDomains
x-amz-request-id
T523X2H19HSQRYF1
age
8448
x-amz-server-side-encryption
AES256
x-amz-replication-status
REPLICA
alt-svc
h3=":443"; ma=86400
x-amz-id-2
nwElIoxq6pDR27e/nxQ2cnKCIOAPQ+F5GfiiG1OKZPKIwqtBIinBgBz9Guhktiq5fJwSCPDEXjg=
last-modified
Wed, 21 Feb 2024 14:01:48 GMT
server
cloudflare
etag
W/"05cb4323604ef6b2615d85e4c62171ae"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=14400
cf-ray
85b9dc1ceabfbbc2-FRA
expires
Mon, 26 Feb 2024 21:20:37 GMT
recaptcha__en_gb.js
www.gstatic.com/recaptcha/releases/1kRDYC3bfA-o6-tsWzIBvp7k/
492 KB
196 KB
Script
General
Full URL
https://www.gstatic.com/recaptcha/releases/1kRDYC3bfA-o6-tsWzIBvp7k/recaptcha__en_gb.js
Requested by
Host: www.google.com
URL: https://www.google.com/recaptcha/api.js?hl=en-GB
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80b::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1ee6483fd88f36a4623b42c8d48ae3b04d013f511882265fa5534aaab3b77a35
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.biopharma-reporter.com/
Origin
https://www.biopharma-reporter.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Tue, 20 Feb 2024 21:22:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
503905
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
200125
x-xss-protection
0
last-modified
Mon, 19 Feb 2024 05:01:55 GMT
server
sffe
cross-origin-opener-policy
same-origin-allow-popups; report-to="recaptcha"
vary
Accept-Encoding
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Wed, 19 Feb 2025 21:22:12 GMT
WR_Monoblack_RGB.svg
resources.wrbm.com/logo/
5 KB
2 KB
Image
General
Full URL
https://resources.wrbm.com/logo/WR_Monoblack_RGB.svg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
13.80.151.158 Amsterdam, Netherlands, ASN8075 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
1a6dd3ac5206ec5fdcdb19f80f0417fb5fa242865feb59cdc758fd787b9895e3

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
last-modified
Mon, 31 Jan 2022 14:27:41 GMT
server
Microsoft-IIS/10.0
etag
"80ec26b4ae16d81:0"
x-powered-by
ASP.NET
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
no-cache
accept-ranges
bytes
content-length
2064
pubads_impl.js
securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402200101/
428 KB
135 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202402200101/pubads_impl.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
7ae3dcf8002e428f15567c5a304172fe086cf525cc41c02a83c091989152e4cf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 10:40:34 GMT
content-encoding
br
x-content-type-options
nosniff
age
24003
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
137981
x-xss-protection
0
server
cafe
etag
12437356588311396475
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, immutable, max-age=31536000
timing-allow-origin
*
expires
Tue, 25 Feb 2025 10:40:34 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
71 B
74 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.biopharma-reporter.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:827::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
4a8230e6f44253a04aebef2abde63455350b9d3989aa3e223e17bea825c433d7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
br
x-content-type-options
nosniff
server
cafe
content-type
application/json; charset=UTF-8
access-control-allow-origin
*
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
50
x-xss-protection
0
expires
Mon, 26 Feb 2024 17:20:38 GMT
WATCH-Cell-and-gene-therapy-manufacturing-panel-at-Advanced-Therapies-Week-2024.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/05/watch-cell-and-gene-therapy-manufa...
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/05/watch-cell-and-gene-therapy-manufacturing-panel-at-advanced-therapies-week-2024/17138717-1-eng-GB/WATCH-Cell-and-gene-therapy-manufacturing-panel-at-Advanced-Therapies-Week-2024.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
56c5b0819d8610593b31da259eb5759a57b75396ed5956a5ca27dd444e993d68
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Mon, 05 Feb 2024 11:33:51 GMT
age
301721
traceresponse
00-17b666f64f1e06741a077840a3bc8899-9ee377f4fb901b47-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
3852
x-xss-protection
1; mode=block
Beyond-chemotherapy-Navigating-the-promise-and-perils-of-CAR-T-therapy-in-pediatric-cancer.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/01/beyond-chemotherapy-navigating-the...
5 KB
5 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/02/01/beyond-chemotherapy-navigating-the-promise-and-perils-of-car-t-therapy-in-pediatric-cancer/17132672-1-eng-GB/Beyond-chemotherapy-Navigating-the-promise-and-perils-of-CAR-T-therapy-in-pediatric-cancer.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
a0c466313284b1ef8a7490eb2166046dd687cbd11a7409a33b51c2430453a2c9
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 01 Feb 2024 13:55:10 GMT
age
342886
traceresponse
00-17b64185e8e87ff35585a8fec4c90808-1bce3a747ac6cdbc-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
4952
x-xss-protection
1; mode=block
US-Department-of-Defense-funds-MediWound-s-non-surgical-burn-treatment.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/us-department-of-defense-f...
5 KB
5 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/us-department-of-defense-funds-mediwound-s-non-surgical-burn-treatment/17043224-1-eng-GB/US-Department-of-Defense-funds-MediWound-s-non-surgical-burn-treatment.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
024e20c497cfd87ac2d132ef93c42573402c19456480f114cc0f7830e3b9f121
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Tue, 02 Jan 2024 11:32:01 GMT
age
222649
traceresponse
00-17b6aee0ae7d65b85b155c00a5e6720d-e39b9d21088be7ca-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
5112
x-xss-protection
1; mode=block
The-top-5-ADC-startups-favoured-by-venture-capital-investors.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/the-top-5-adc-startups-...
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/the-top-5-adc-startups-favoured-by-venture-capital-investors/17034786-1-eng-GB/The-top-5-ADC-startups-favoured-by-venture-capital-investors.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
19271b2228a30874a4eaa9a4e886d0fb3f6f3c6b9d00c347c4a376a980385535
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 21 Dec 2023 12:55:08 GMT
age
222649
traceresponse
00-17b6aee0ac06cc5bee2be504b7094a82-8f5306797c050bfd-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
4280
x-xss-protection
1; mode=block
Podcast-The-British-start-up-taking-psychedelic-therapy-mainstream.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/10/16/podcast-the-british-start-up-takin...
2 KB
2 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/article/2023/10/16/podcast-the-british-start-up-taking-psychedelic-therapy-mainstream/16842411-1-eng-GB/Podcast-The-British-start-up-taking-psychedelic-therapy-mainstream.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
10d2fb49b134e35afbb3e84842709f49e7090d276bab57b2d9f5cd09168802a6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 19 Oct 2023 09:39:32 GMT
age
342886
traceresponse
00-17b64185e9e1a36e64022c6b4faf1ca8-e93968dce67ca7ea-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
2221
x-xss-protection
1; mode=block
Psychoactive-drug-methylone-tested-as-new-PSTD-treatment-in-London-trial.jpg
www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/psychoactive-drug-methylon...
4 KB
4 KB
Image
General
Full URL
https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_tiny/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/psychoactive-drug-methylone-tested-as-new-pstd-treatment-in-london-trial/16856844-1-eng-GB/Psychoactive-drug-methylone-tested-as-new-PSTD-treatment-in-London-trial.jpg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
0d046d75662fc752968c695d2bef2cd8b4f85c4601487127501c2209926f33e8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:37 GMT
x-content-type-options
nosniff
last-modified
Thu, 19 Oct 2023 11:31:16 GMT
age
301721
traceresponse
00-17b666f6518c820814bafa37bb46dc5d-239e6e0f5be867fb-01
x-frame-options
SAMEORIGIN
content-type
image/jpeg
cache-control
max-age=86400, public, stale-while-revalidate=3600
content-transfer-encoding
binary
accept-ranges
bytes
content-length
3739
x-xss-protection
1; mode=block
neolane_user_data
www.biopharma-reporter.com/gtm/
47 B
207 B
XHR
General
Full URL
https://www.biopharma-reporter.com/gtm/neolane_user_data
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/js/559e323.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
650ae6b29b050c74f97132bac8a34169082908ec5f5a0d397b503f6a4a79b786
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Referer
https://www.biopharma-reporter.com/
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
date
Mon, 26 Feb 2024 17:20:38 GMT
last-modified
Mon, 26 Feb 2024 17:20:38 GMT
age
0
traceresponse
00-17b77960466294575cc16595aaf6bd6c-dc93a63be18e1854-01
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/json
cache-control
max-age=0, private
accept-ranges
bytes
content-length
67
x-xss-protection
1; mode=block
active_popup_info
www.biopharma-reporter.com/
7 KB
3 KB
XHR
General
Full URL
https://www.biopharma-reporter.com/active_popup_info
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/js/559e323.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.194.137 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
/
Resource Hash
b2d1d8555a1a905bb1b3ad6d5f146d19c06418ba9fd3ee7d238e1542cd296a9d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Referer
https://www.biopharma-reporter.com/
X-Requested-With
XMLHttpRequest
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
date
Mon, 26 Feb 2024 17:20:37 GMT
age
83840
traceresponse
00-17b72d1fcd366942aa40bb52c0aaa00d-32d7f35934b7cabe-01
x-frame-options
SAMEORIGIN
vary
Accept-Encoding
content-type
application/json
cache-control
max-age=3600, public
accept-ranges
bytes
content-length
2509
x-xss-protection
1; mode=block
otBannerSdk.js
cdn.cookielaw.org/scripttemplates/202401.2.0/
429 KB
105 KB
Script
General
Full URL
https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/otSDKStub.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
619961cc5419607d2024e330d6c57c6574bf7610260fb43362fbbcc800854d5e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
S1Y6/40RYuKp4yHMipHDTg==
age
30884
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-length
106707
x-ms-lease-status
unlocked
last-modified
Mon, 26 Feb 2024 03:25:08 GMT
server
cloudflare
etag
0x8DC367A88B71ACE
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
x-ms-request-id
9c2ae3a7-001e-0072-3a8f-683ecc000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1d8880926e-FRA
cx.cce.js
cdn.cxense.com/
23 KB
6 KB
Script
General
Full URL
https://cdn.cxense.com/cx.cce.js
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:480:ba2::268b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
4b80e46450200d3fabd65323bf5a91b8d31e919438a8cd48b9f8e8bd8b23edac

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

Date
Mon, 26 Feb 2024 17:20:38 GMT
Content-Encoding
gzip
Last-Modified
Fri, 01 Dec 2023 11:02:02 GMT
Server
AkamaiNetStorage
Vary
Accept-Encoding
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
6055
Expires
Mon, 26 Feb 2024 18:20:38 GMT
execute
c2.piano.io/xbuilder/experience/
1 KB
1 KB
XHR
General
Full URL
https://c2.piano.io/xbuilder/experience/execute?aid=1f6nyjoJpu
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6811:c276 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8c65ff287dc0e9fcb7f01cc814e259d4fa950fa732a8f9262b14a5091b608def
Security Headers
Name Value
Strict-Transport-Security max-age=86400; includeSubDomains

Request headers

Accept
application/json
Referer
https://www.biopharma-reporter.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
strict-transport-security
max-age=86400; includeSubDomains
content-encoding
br
cf-cache-status
DYNAMIC
alt-svc
h3=":443"; ma=86400
x-request-id
qxqhrrpxbc
pragma
no-cache
server
cloudflare
vary
Accept-Encoding, Origin
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json; charset=UTF-8
access-control-allow-origin
https://www.biopharma-reporter.com
access-control-expose-headers
Composer-Request-Control-Policy
cache-control
no-cache, no-store
access-control-allow-credentials
true
cf-ray
85b9dc1e4f4503e4-FRA
en.json
cdn.cookielaw.org/consent/3649966f-cab2-4eb8-af76-2efa9af8e3a7/e9f2ec58-da64-4510-9911-08b2cf3810bb/
219 KB
42 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/consent/3649966f-cab2-4eb8-af76-2efa9af8e3a7/e9f2ec58-da64-4510-9911-08b2cf3810bb/en.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
80c7cfc58aece4ee2ca5b3975d5a032334bcbbef2b1c7372b8cc89bebc37e7d4
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
strict-transport-security
max-age=31536000; includeSubDomains; preload
age
43764
content-md5
bcTYQ7uo2Lvt6F5wOj+14w==
content-length
42842
x-ms-lease-status
unlocked
last-modified
Mon, 12 Feb 2024 10:46:29 GMT
server
cloudflare
etag
0x8DC2BB7DEA52786
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
*
x-ms-request-id
46282eec-a01e-0036-66a0-5db4f3000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1e4c765d50-FRA
expires
Tue, 27 Feb 2024 17:20:38 GMT
iab2V2Data.json
cdn.cookielaw.org/vendorlist/
553 KB
72 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/vendorlist/iab2V2Data.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
96fafe4a36a0db600be149e2ca0ea5457c3db870a3e905b2be459d37928bdb2a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
1JfYxNiR9vOGrhf+cjQkEA==
age
28717
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-length
73113
x-ms-lease-status
unlocked
last-modified
Sun, 25 Feb 2024 22:09:28 GMT
server
cloudflare
etag
0x8DC364E6F7337F3
vary
Accept-Encoding
content-type
application/x-javascript
access-control-allow-origin
*
x-ms-request-id
2691cc9d-e01e-009e-3442-682a5d000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Cache-Control,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
public, max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1e4c775d50-FRA
otTCF.js
cdn.cookielaw.org/scripttemplates/202401.2.0/
60 KB
17 KB
Script
General
Full URL
https://cdn.cookielaw.org/scripttemplates/202401.2.0/otTCF.js
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e40e7b46b99c06e47841ff53e4417b6c887631d383aac28114e4ab83ccddc6f7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
ONII5aJIakWkasTKn2tKxA==
age
23554
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-length
17104
x-ms-lease-status
unlocked
last-modified
Mon, 26 Feb 2024 03:25:07 GMT
server
cloudflare
etag
0x8DC367A87F48396
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
x-ms-request-id
cbd6baf5-301e-0034-1b8a-680a4b000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1e490b926e-FRA
js
www.googletagmanager.com/gtag/
233 KB
82 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-6SGBRT2KVQ&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PBQBMR
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
3b659f0bcf1b910314e52e04fa52d49ebcaa1cd9831728c2c34cdbf8014b75b3
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
83673
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Mon, 26 Feb 2024 17:20:38 GMT
js
www.googletagmanager.com/gtag/
251 KB
86 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-GMENJXB1ZX&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PBQBMR
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:812::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
d0b67779ff00830dd9ba7415b7110c4f18536412aefc3a62e65640c0078bbf62
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
87491
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Mon, 26 Feb 2024 17:20:38 GMT
insight.min.js
snap.licdn.com/li.lms-analytics/
45 KB
16 KB
Script
General
Full URL
https://snap.licdn.com/li.lms-analytics/insight.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-PBQBMR
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:3500:16::215:1484 Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
/
Resource Hash
e9841d9258210b13f0870a80d02ce8f3224c8798d1c0d618f210a573ce96038e
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 20 Feb 2024 09:12:49 GMT
x-cdn
AKAM
x-amz-server-side-encryption
AES256
vary
Accept-Encoding
content-type
application/javascript;charset=utf-8
cache-control
max-age=76251
accept-ranges
bytes
content-length
16480
fbevents.js
connect.facebook.net/en_US/
214 KB
58 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f007:8:face:b00c:0:1 , United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
0e04153b5f73bfa7866948f2a9870593d69bfde14e77a1a06af5f567096e5a09
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

permissions-policy-report-only
clipboard-read=(), clipboard-write=(), picture-in-picture=();report-to="permissions_policy"
content-security-policy
default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
57257
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
pragma
public
x-fb-debug
pvI3KBF+bd13M+FHPNjca87p0hgqsCqpXefaUtWqYhvGhZA16lSYR3DqfPsHQd+CBjiGe1fRDg14uW22frIVKQ==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), autoplay=(), bluetooth=(), camera=(), display-capture=(), encrypted-media=(), fullscreen=(self), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), usb=(), window-management=(), xr-spatial-tracking=();report-to="permissions_policy"
timing-allow-origin
*
expires
Sat, 01 Jan 2000 00:00:00 GMT
cx.js
cdn.cxense.com/
112 KB
37 KB
Script
General
Full URL
https://cdn.cxense.com/cx.js
Requested by
Host: cdn.cxense.com
URL: https://cdn.cxense.com/cx.cce.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:480:ba2::268b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
7ed8449e80031b5df4775df66f21bafb7607ec5db63f4a77e6b90998a2f193da

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

Date
Mon, 26 Feb 2024 17:20:38 GMT
Content-Encoding
gzip
Last-Modified
Thu, 22 Feb 2024 06:15:44 GMT
Server
AkamaiNetStorage
Vary
Accept-Encoding
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
37361
Expires
Mon, 26 Feb 2024 18:20:38 GMT
otCenterRounded.json
cdn.cookielaw.org/scripttemplates/202401.2.0/assets/
9 KB
3 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/scripttemplates/202401.2.0/assets/otCenterRounded.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
09b627933e01faa4979dc5661f7e616c7db1c12ea1984ca0549bdb253d24da9b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
TAJflDtOI2DBucn5o4BVKw==
age
28717
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-length
2626
x-ms-lease-status
unlocked
last-modified
Thu, 15 Feb 2024 03:26:18 GMT
server
cloudflare
etag
0x8DC2DD5DF8AE162
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
x-ms-request-id
efdc788b-601e-0029-2360-6007f7000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1f2ce05d50-FRA
otPcTab.json
cdn.cookielaw.org/scripttemplates/202401.2.0/assets/v2/
63 KB
13 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/scripttemplates/202401.2.0/assets/v2/otPcTab.json
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d18f313f2489ed91cd15cf94a1e5668b8b0da8318f593d980228000a1757702f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
1jrazjAE7ub00sUl433JbA==
age
79402
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-length
13587
x-ms-lease-status
unlocked
last-modified
Thu, 15 Feb 2024 03:26:19 GMT
server
cloudflare
etag
0x8DC2DD5E09A2DF1
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
x-ms-request-id
bc4cb849-001e-002f-1460-603448000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Content-Encoding,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1f2ce15d50-FRA
otCommonStyles.css
cdn.cookielaw.org/scripttemplates/202401.2.0/assets/
21 KB
4 KB
Fetch
General
Full URL
https://cdn.cookielaw.org/scripttemplates/202401.2.0/assets/otCommonStyles.css
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
d3f7b0ec4de079928a999641e781e80f33597a392a561bc460276dfb4efb6eec
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
content-md5
c7xAZ9MSGAobGaTYg/Qtag==
age
28717
x-ms-lease-status
unlocked
last-modified
Thu, 15 Feb 2024 03:26:28 GMT
server
cloudflare
vary
Accept-Encoding
content-type
text/css
access-control-allow-origin
*
x-ms-request-id
92c6238b-101e-00a5-2d61-606ff9000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
cf-ray
85b9dc1f2ce35d50-FRA
collect
region1.analytics.google.com/g/
0
45 B
Ping
General
Full URL
https://region1.analytics.google.com/g/collect?v=2&tid=G-6SGBRT2KVQ&gtm=45je42l0v9135680113z86649612za200&_p=1708968038108&_gaz=1&gcd=13l3l3l3l1&npa=0&dma_cps=sypham&dma=1&tcfd=10001&cid=1369008900.1708968038&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&sid=1708968038&sct=1&seg=0&dl=https%3A%2F%2Fwww.biopharma-reporter.com%2F&dt=Biopharmaceutical%20Manufacturing%2C%20Upstream%2C%20Downstream%20processing%20news&en=page_view&_fv=1&_nsi=1&_ss=1&tfd=1017
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-6SGBRT2KVQ&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
262 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-6SGBRT2KVQ&cid=1369008900.1708968038&gtm=45je42l0v9135680113z86649612za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l3l1&npa=0
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-6SGBRT2KVQ&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c00::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
107 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-6SGBRT2KVQ&cid=1369008900.1708968038&gtm=45je42l0v9135680113z86649612za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l3l1&npa=0&z=1485546758
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
region1.analytics.google.com/g/
0
253 B
Ping
General
Full URL
https://region1.analytics.google.com/g/collect?v=2&tid=G-GMENJXB1ZX&gtm=45je42l0v9135730596z86649612za200&_p=1708968038108&_gaz=1&gcd=13l3l3l3l1&npa=0&dma_cps=sypham&dma=1&tcfd=10001&cid=1369008900.1708968038&ul=en-us&sr=1600x1200&ir=1&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_eu=EA&_s=1&sid=1708968038&sct=1&seg=0&dl=https%3A%2F%2Fwww.biopharma-reporter.com%2F&dt=Biopharmaceutical%20Manufacturing%2C%20Upstream%2C%20Downstream%20processing%20news&en=page_view&_fv=1&_ss=1&tfd=1036
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-GMENJXB1ZX&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
45 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-GMENJXB1ZX&cid=1369008900.1708968038&gtm=45je42l0v9135730596z86649612za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l3l1&npa=0
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-GMENJXB1ZX&l=dataLayer&cx=c
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c00::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
408 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-GMENJXB1ZX&cid=1369008900.1708968038&gtm=45je42l0v9135730596z86649612za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l3l1&npa=0&z=2115553088
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
px4.ads.linkedin.com/
Redirect Chain
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true
  • https://www.linkedin.com/px/li_sync?redirect=https%3A%2F%2Fpx.ads.linkedin.com%2Fcollect%3Fv%3D2%26fmt%3Djs%26pid%3D197740%26time%3D1708968038305%26li_adsId%3D6d8a1820-ea58-4de1-b69a-a57d8d836dbe%2...
  • https://px.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true&liSync=true
  • https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true&liSync=t...
0
265 B
Image
General
Full URL
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true&liSync=true&e_ipv6=AQIZZjL98Aq4xgAAAY3mbtIGUNvAosIt64J9vhpvDqYuZjvd9_5KEVoya1hamp-kzLwntjJO
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Server
13.107.42.14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
x-li-pop
afd-prod-lva1-x
x-msedge-ref
Ref A: DB4DF1B9943046EB9D796676F1C07172 Ref B: FRAEDGE2014 Ref C: 2024-02-26T17:20:39Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
content-type
application/javascript
x-li-fabric
prod-lva1
x-li-proto
http/2
content-length
0
x-li-uuid
AAYSTCDnvQiczGQfV7nWsQ==

Redirect headers

date
Mon, 26 Feb 2024 17:20:38 GMT
x-li-pop
afd-prod-lva1-x
x-msedge-ref
Ref A: 55D2D4B889234474BACD98E9FF8DE3FB Ref B: FRAEDGE1212 Ref C: 2024-02-26T17:20:38Z
linkedin-action
1
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-lva1
location
https://px4.ads.linkedin.com/collect?v=2&fmt=js&pid=197740&time=1708968038305&li_adsId=6d8a1820-ea58-4de1-b69a-a57d8d836dbe&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&cookiesTest=true&liSync=true&e_ipv6=AQIZZjL98Aq4xgAAAY3mbtIGUNvAosIt64J9vhpvDqYuZjvd9_5KEVoya1hamp-kzLwntjJO
x-li-proto
http/2
content-length
0
x-li-uuid
AAYSTCDkR+5JjCK+Solldw==
ot_guard_logo.svg
cdn.cookielaw.org/logos/static/
497 B
511 B
Fetch
General
Full URL
https://cdn.cookielaw.org/logos/static/ot_guard_logo.svg
Requested by
Host: cdn.cookielaw.org
URL: https://cdn.cookielaw.org/scripttemplates/202401.2.0/otBannerSdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
691dcdb24853a0f5ce4e6597e5713dea66799b57ffe2c2a10f28f98e0b569b19
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
content-md5
tXyZydHjxQshFMbbBT1/8A==
age
79402
x-ms-lease-status
unlocked
last-modified
Fri, 23 Feb 2024 20:10:23 GMT
server
cloudflare
vary
Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
x-ms-request-id
b5f73465-e01e-0037-41bb-66eb2f000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
cf-ray
85b9dc1fad855d50-FRA
WR-ONETRUST.png
cdn.cookielaw.org/logos/39a613a7-9277-4777-ae10-0aa12b902a59/503c82eb-c685-4a82-8928-be20159d41ed/39a840e4-f779-4654-ace4-b7a18a397965/
2 KB
2 KB
Image
General
Full URL
https://cdn.cookielaw.org/logos/39a613a7-9277-4777-ae10-0aa12b902a59/503c82eb-c685-4a82-8928-be20159d41ed/39a840e4-f779-4654-ace4-b7a18a397965/WR-ONETRUST.png
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
128d8c875154f5af76f013d6203089aa29e56a7af7244bc121df555e6d140419
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
iZ0B4+4yXLmts9IPnOYraQ==
age
22024
content-length
1772
x-ms-lease-status
unlocked
last-modified
Fri, 09 Feb 2024 10:35:18 GMT
server
cloudflare
etag
0x8DC295ACFC9BEB0
vary
Accept-Encoding
content-type
image/png
access-control-allow-origin
*
x-ms-request-id
5cc2a9ac-b01e-0077-5043-5bec17000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1faa32926e-FRA
WR-ONETRUST.png
cdn.cookielaw.org/logos/39a613a7-9277-4777-ae10-0aa12b902a59/b98d531b-cfd9-4a3b-a21a-59948d7fa730/f1e21bba-7efb-4553-8741-5be1610af2ae/
2 KB
2 KB
Image
General
Full URL
https://cdn.cookielaw.org/logos/39a613a7-9277-4777-ae10-0aa12b902a59/b98d531b-cfd9-4a3b-a21a-59948d7fa730/f1e21bba-7efb-4553-8741-5be1610af2ae/WR-ONETRUST.png
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
128d8c875154f5af76f013d6203089aa29e56a7af7244bc121df555e6d140419
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
content-md5
iZ0B4+4yXLmts9IPnOYraQ==
age
11602
content-length
1772
x-ms-lease-status
unlocked
last-modified
Tue, 09 Jan 2024 11:06:50 GMT
server
cloudflare
etag
0x8DC110314A0B526
vary
Accept-Encoding
content-type
image/png
access-control-allow-origin
*
x-ms-request-id
9013281f-301e-001b-2035-450780000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
accept-ranges
bytes
cf-ray
85b9dc1faa33926e-FRA
powered_by_logo.svg
cdn.cookielaw.org/logos/static/
5 KB
2 KB
Image
General
Full URL
https://cdn.cookielaw.org/logos/static/powered_by_logo.svg
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:83ec , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5fa00d047acd959697b9d7772c31dcd37bec33c70c6fbf80ab8316205d1d286d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

x-ms-blob-type
BlockBlob
date
Mon, 26 Feb 2024 17:20:38 GMT
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
cf-cache-status
HIT
content-encoding
gzip
content-md5
Y+c301RBZNK39PvKQWrIBw==
age
38658
x-ms-lease-status
unlocked
last-modified
Mon, 26 Feb 2024 03:25:13 GMT
server
cloudflare
vary
Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
x-ms-request-id
44a1d4fa-001e-002f-1067-683448000000
access-control-expose-headers
x-ms-request-id,Server,x-ms-version,Content-Type,Last-Modified,ETag,Content-MD5,x-ms-lease-status,x-ms-blob-type,Content-Length,Date,Transfer-Encoding
cache-control
max-age=86400
x-ms-version
2009-09-19
cf-ray
85b9dc1faa35926e-FRA
sp1.html
cdn.cxense.com/ Frame 5DB9
456 B
659 B
Document
General
Full URL
https://cdn.cxense.com/sp1.html
Requested by
Host: cdn.cxense.com
URL: https://cdn.cxense.com/cx.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:480:ba2::268b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
1643f549380aeab61b23502d9f260f7350d9c2bd34dbc3cb0af73644332b6ef5

Request headers

Referer
https://www.biopharma-reporter.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

Accept-Ranges
bytes
Access-Control-Allow-Origin
*
Cache-Control
max-age=864000
Connection
keep-alive
Content-Encoding
gzip
Content-Length
289
Content-Type
text/html
Date
Mon, 26 Feb 2024 17:20:38 GMT
Expires
Thu, 07 Mar 2024 17:20:38 GMT
Last-Modified
Thu, 30 Nov 2023 11:55:50 GMT
Server
AkamaiNetStorage
Vary
Accept-Encoding
646689182168886
connect.facebook.net/signals/config/
53 KB
11 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/646689182168886?v=2.9.147&r=stable&domain=www.biopharma-reporter.com&hme=20c913bdcd4be51a752120153aa5caaecb3ee86c7f26cf737846e40b202aba68&ex_m=62%2C106%2C94%2C98%2C53%2C3%2C88%2C61%2C14%2C86%2C79%2C44%2C46%2C150%2C153%2C164%2C160%2C161%2C163%2C25%2C89%2C45%2C68%2C162%2C145%2C148%2C157%2C158%2C165%2C115%2C13%2C43%2C169%2C168%2C117%2C16%2C29%2C32%2C1%2C36%2C57%2C58%2C59%2C63%2C83%2C15%2C12%2C85%2C82%2C81%2C95%2C97%2C31%2C96%2C26%2C22%2C146%2C149%2C124%2C24%2C9%2C10%2C11%2C5%2C6%2C21%2C19%2C20%2C49%2C54%2C56%2C66%2C90%2C23%2C67%2C8%2C7%2C71%2C41%2C18%2C92%2C91%2C17%2C4%2C73%2C80%2C72%2C78%2C40%2C39%2C77%2C33%2C35%2C76%2C48%2C74%2C28%2C37%2C65%2C0%2C84%2C75%2C2%2C30%2C55%2C34%2C93%2C38%2C70%2C60%2C99%2C52%2C51%2C27%2C87%2C50%2C47%2C42%2C69%2C64%2C100
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f007:8:face:b00c:0:1 , United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
e6d56e7be5e8cc74dbab03f36826a89332c00ab367b6ffc89405fe823b80057e
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

permissions-policy-report-only
clipboard-read=(), clipboard-write=(), picture-in-picture=();report-to="permissions_policy"
content-security-policy
default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
pragma
public
x-fb-debug
Bw9FIamZd2HKvTd8GRAChRLIO2anJeyJkHnf/oZGcvLtMOrqTQMXL9uaq8IyhUmGhvMBd1dirvL19pRGdjFitw==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), autoplay=(), bluetooth=(), camera=(), display-capture=(), encrypted-media=(), fullscreen=(self), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), usb=(), window-management=(), xr-spatial-tracking=();report-to="permissions_policy"
timing-allow-origin
*
expires
Sat, 01 Jan 2000 00:00:00 GMT
cx.js
cdn.cxense.com/ Frame 5DB9
112 KB
37 KB
Script
General
Full URL
https://cdn.cxense.com/cx.js
Requested by
Host: cdn.cxense.com
URL: https://cdn.cxense.com/sp1.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
2a02:26f0:480:ba2::268b Frankfurt am Main, Germany, ASN20940 (AKAMAI-ASN1, NL),
Reverse DNS
Software
AkamaiNetStorage /
Resource Hash
0d8dc212b1baf8e4c6069aae46c1e737b7a5e230eddff37c12bdb1ff9b75868b

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://cdn.cxense.com/sp1.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

Date
Mon, 26 Feb 2024 17:20:38 GMT
Content-Encoding
gzip
Last-Modified
Thu, 22 Feb 2024 06:15:44 GMT
Server
AkamaiNetStorage
Vary
Accept-Encoding
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=3600
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
37361
Expires
Mon, 26 Feb 2024 18:20:38 GMT
p1.js
p1cluster.cxense.com/ Frame 5DB9
47 B
638 B
Script
General
Full URL
https://p1cluster.cxense.com/p1.js
Requested by
Host: cdn.cxense.com
URL: https://cdn.cxense.com/cx.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
167.235.124.59 Bühl, Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
nue0037.cxense.com
Software
Jetty(9.4.28.v20200408) /
Resource Hash
3d6495df95d6c2b0ca18605427de46b2f27e8d375b4831692a128644f14022e2

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://cdn.cxense.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
last-modified
Sat, 26 Aug 2023 17:20:38 GMT
server
Jetty(9.4.28.v20200408)
etag
1y6nbvinlltzn3bp4o2qkahz3p
p3p
policyref="http://www.cxense.com/w3c/p3p.xml", CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
content-type
text/javascript;charset=utf-8
cache-control
private, proxy-revalidate
content-length
47
expires
Wed, 26 Feb 2025 17:20:38 GMT
1520333554732973
connect.facebook.net/signals/config/
30 KB
5 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1520333554732973?v=2.9.147&r=stable&domain=www.biopharma-reporter.com&hme=20c913bdcd4be51a752120153aa5caaecb3ee86c7f26cf737846e40b202aba68&ex_m=62%2C106%2C94%2C98%2C53%2C3%2C88%2C61%2C14%2C86%2C79%2C44%2C46%2C150%2C153%2C164%2C160%2C161%2C163%2C25%2C89%2C45%2C68%2C162%2C145%2C148%2C157%2C158%2C165%2C115%2C13%2C43%2C169%2C168%2C117%2C16%2C29%2C32%2C1%2C36%2C57%2C58%2C59%2C63%2C83%2C15%2C12%2C85%2C82%2C81%2C95%2C97%2C31%2C96%2C26%2C22%2C146%2C149%2C124%2C24%2C9%2C10%2C11%2C5%2C6%2C21%2C19%2C20%2C49%2C54%2C56%2C66%2C90%2C23%2C67%2C8%2C7%2C71%2C41%2C18%2C92%2C91%2C17%2C4%2C73%2C80%2C72%2C78%2C40%2C39%2C77%2C33%2C35%2C76%2C48%2C74%2C28%2C37%2C65%2C0%2C84%2C75%2C2%2C30%2C55%2C34%2C93%2C38%2C70%2C60%2C99%2C52%2C51%2C27%2C87%2C50%2C47%2C42%2C69%2C64%2C100%2C175%2C174%2C176%2C181%2C182%2C183%2C179%2C171%2C116%2C170%2C172%2C107%2C137%2C129%2C132%2C113%2C166%2C206%2C101%2C207%2C144%2C105%2C127%2C120%2C108
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a03:2880:f007:8:face:b00c:0:1 , United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
a59fb9d0c583b4d8afb7e7b8913ca62d41cfe91bc2556f6a5428542e38909340
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

permissions-policy-report-only
clipboard-read=(), clipboard-write=(), picture-in-picture=();report-to="permissions_policy"
content-security-policy
default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
pragma
public
x-fb-debug
orGv92pKqrbYZD3UPrlaU8Mpit28QDw81AkaymxCJks+IGpvuxl/Dnm9si0YL8wj0JEiERfLqEz6ejwHzQre8A==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), autoplay=(), bluetooth=(), camera=(), display-capture=(), encrypted-media=(), fullscreen=(self), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), usb=(), window-management=(), xr-spatial-tracking=();report-to="permissions_policy"
timing-allow-origin
*
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/
0
185 B
Image
General
Full URL
https://www.facebook.com/tr/?id=646689182168886&ev=PageView&dl=https%3A%2F%2Fwww.biopharma-reporter.com%2F&rl=&if=false&ts=1708968038549&sw=1600&sh=1200&v=2.9.147&r=stable&a=tmgoogletagmanager&ec=0&o=4126&fbp=fb.1.1708968038548.675839586&ler=empty&cdl=API_unavailable&it=1708968038359&coo=false&exp=e1&rqm=GET
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f176:181:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
server
proxygen-bolt
content-type
text/plain
access-control-allow-origin
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
0
rep.gif
comcluster.cxense.com/Repo/ Frame 5DB9
43 B
469 B
Image
General
Full URL
https://comcluster.cxense.com/Repo/rep.gif?ver=2.8.50&typ=pgv&rnd=lt37g1guigtbhoqf&sid=4756159533952406473&loc=https%3A%2F%2Fwww.biopharma-reporter.com%2F&new=1&arf=0&ltm=1708968038303&ref=&tzo=-60&wsz=1600x1200&res=1600x1200&dpr=1&col=24&bln=en-US&chs=UTF-8&cks=lt37g1q29x3u6ewm&ckp=lt37g1guka8vxlxu&glb=&cp_userState=anon&cst=1y6nbvinlltzn3bp4o2qkahz3p
Requested by
Host: cdn.cxense.com
URL: https://cdn.cxense.com/sp1.html
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
167.235.124.59 Bühl, Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
nue0037.cxense.com
Software
Jetty(9.4.28.v20200408) /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://cdn.cxense.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

p3p
policyref="http://www.cxense.com/w3c/p3p.xml", CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
date
Mon, 26 Feb 2024 17:20:38 GMT
server
Jetty(9.4.28.v20200408)
content-length
43
content-type
image/gif
id
id.cxense.com/public/user/
103 B
676 B
Script
General
Full URL
https://id.cxense.com/public/user/id?json=%7B%22identities%22%3A%5B%7B%22type%22%3A%22ckp%22%2C%22id%22%3A%22lt37g1guka8vxlxu%22%7D%2C%7B%22type%22%3A%22lst%22%2C%22id%22%3A%221y6nbvinlltzn3bp4o2qkahz3p%22%7D%2C%7B%22type%22%3A%22cst%22%2C%22id%22%3A%221y6nbvinlltzn3bp4o2qkahz3p%22%7D%5D%2C%22siteId%22%3A%224756159533952406473%22%2C%22location%22%3A%22https%3A%2F%2Fwww.biopharma-reporter.com%2F%22%7D&callback=cXJsonpCB1
Requested by
Host: cdn.cxense.com
URL: https://cdn.cxense.com/cx.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
167.235.124.59 Bühl, Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
nue0037.cxense.com
Software
Jetty(9.4.28.v20200408) /
Resource Hash
350fa1b39ae9539a05bd0c71a87c6362050a4b6a9e03a2a102a00f3e8b2986e6
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:38 GMT
x-content-type-options
nosniff
server
Jetty(9.4.28.v20200408)
content-type
text/javascript;charset=utf-8
p3p
policyref="http://www.cxense.com/w3c/p3p.xml", CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
cache-control
no-store, no-cache, must-revalidate
content-length
103
expires
Mon, 26 Jul 1997 05:00:00 GMT
1028071247578156
connect.facebook.net/signals/config/
27 KB
4 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/1028071247578156?v=2.9.147&r=stable&domain=www.biopharma-reporter.com&hme=20c913bdcd4be51a752120153aa5caaecb3ee86c7f26cf737846e40b202aba68&ex_m=62%2C106%2C94%2C98%2C53%2C3%2C88%2C61%2C14%2C86%2C79%2C44%2C46%2C150%2C153%2C164%2C160%2C161%2C163%2C25%2C89%2C45%2C68%2C162%2C145%2C148%2C157%2C158%2C165%2C115%2C13%2C43%2C169%2C168%2C117%2C16%2C29%2C32%2C1%2C36%2C57%2C58%2C59%2C63%2C83%2C15%2C12%2C85%2C82%2C81%2C95%2C97%2C31%2C96%2C26%2C22%2C146%2C149%2C124%2C24%2C9%2C10%2C11%2C5%2C6%2C21%2C19%2C20%2C49%2C54%2C56%2C66%2C90%2C23%2C67%2C8%2C7%2C71%2C41%2C18%2C92%2C91%2C17%2C4%2C73%2C80%2C72%2C78%2C40%2C39%2C77%2C33%2C35%2C76%2C48%2C74%2C28%2C37%2C65%2C0%2C84%2C75%2C2%2C30%2C55%2C34%2C93%2C38%2C70%2C60%2C99%2C52%2C51%2C27%2C87%2C50%2C47%2C42%2C69%2C64%2C100%2C175%2C174%2C176%2C181%2C182%2C183%2C179%2C171%2C116%2C170%2C172%2C107%2C137%2C129%2C132%2C113%2C166%2C206%2C101%2C207%2C144%2C105%2C127%2C120%2C108%2C118%2C111
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a03:2880:f007:8:face:b00c:0:1 , United States, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
/
Resource Hash
50bd45b5662fd10dd4b37357b041db51f279d8141e74a53f2792f1e329afc5c2
Security Headers
Name Value
Content-Security-Policy default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

permissions-policy-report-only
clipboard-read=(), clipboard-write=(), picture-in-picture=();report-to="permissions_policy"
content-security-policy
default-src 'self' data: blob: facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;script-src *.fbcdn.net *.facebook.net 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' facebook.net *.facebook.net fbcdn.net *.fbcdn.net fbsbx.com *.fbsbx.com;connect-src *.fbcdn.net *.facebook.net wss://*.fbcdn.net attachment.fbsbx.com blob: 'self';block-all-mixed-content;upgrade-insecure-requests;report-uri https://www.facebook.com/csp/reporting/?m=c&minimize=0;require-trusted-types-for 'script';
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000; preload; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
document-policy
force-load-at-top
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
x-xss-protection
0
reporting-endpoints
coop_report="https://www.facebook.com/browser_reporting/coop/?minimize=0", coep_report="https://www.facebook.com/browser_reporting/coep/?minimize=0", permissions_policy="https://www.facebook.com/ajax/browser_error_reports/"
pragma
public
x-fb-debug
bmG1hOwuXKAgvxJa0GNhpNv2ALYBYg8YQS9f1hvmxm8kGmSpZ0mT9tqyQpbdCjZ8f/fDkie9/m7zTmrmepHTgw==
cross-origin-embedder-policy-report-only
require-corp;report-to="coep_report"
cross-origin-opener-policy
same-origin-allow-popups;report-to="coop_report"
vary
Accept-Encoding
report-to
{"max_age":2592000,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coop\/?minimize=0"}],"group":"coop_report","include_subdomains":true}, {"max_age":86400,"endpoints":[{"url":"https:\/\/www.facebook.com\/browser_reporting\/coep\/?minimize=0"}],"group":"coep_report"}, {"max_age":21600,"endpoints":[{"url":"https:\/\/www.facebook.com\/ajax\/browser_error_reports\/"}],"group":"permissions_policy"}
content-type
application/x-javascript; charset=utf-8
x-frame-options
DENY
origin-agent-cluster
?0
cache-control
public, max-age=1200
permissions-policy
accelerometer=(), ambient-light-sensor=(), autoplay=(), bluetooth=(), camera=(), display-capture=(), encrypted-media=(), fullscreen=(self), gamepad=(), geolocation=(), gyroscope=(), hid=(), idle-detection=(), keyboard-map=(), local-fonts=(), magnetometer=(), microphone=(), midi=(), otp-credentials=(), payment=(), publickey-credentials-get=(), screen-wake-lock=(), serial=(), usb=(), window-management=(), xr-spatial-tracking=();report-to="permissions_policy"
timing-allow-origin
*
priority
u=3,i
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/
0
31 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1520333554732973&ev=PageView&dl=https%3A%2F%2Fwww.biopharma-reporter.com%2F&rl=&if=false&ts=1708968038746&sw=1600&sh=1200&v=2.9.147&r=stable&a=tmgoogletagmanager&ec=0&o=4126&fbp=fb.1.1708968038548.675839586&ler=empty&cdl=API_unavailable&cs_est=true&it=1708968038359&coo=false&exp=e1&rqm=GET
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f176:181:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
server
proxygen-bolt
content-type
text/plain
access-control-allow-origin
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
0
/
www.facebook.com/tr/
0
18 B
Image
General
Full URL
https://www.facebook.com/tr/?id=1028071247578156&ev=PageView&dl=https%3A%2F%2Fwww.biopharma-reporter.com%2F&rl=&if=false&ts=1708968038936&sw=1600&sh=1200&v=2.9.147&r=stable&a=tmgoogletagmanager&ec=0&o=4126&fbp=fb.1.1708968038548.675839586&ler=empty&cdl=API_unavailable&cs_est=true&it=1708968038359&coo=false&exp=e1&rqm=GET
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a03:2880:f176:181:face:b00c:0:25de Frankfurt am Main, Germany, ASN32934 (FACEBOOK, US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; includeSubDomains
date
Mon, 26 Feb 2024 17:20:38 GMT
server
proxygen-bolt
content-type
text/plain
access-control-allow-origin
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400
content-length
0
priority
u=3,i
/
px.ads.linkedin.com/wa/
0
203 B
XHR
General
Full URL
https://px.ads.linkedin.com/wa/
Requested by
Host: snap.licdn.com
URL: https://snap.licdn.com/li.lms-analytics/insight.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2620:1ec:21::14 , United States, ASN8068 (MICROSOFT-CORP-MSN-AS-BLOCK, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept
*
Referer
https://www.biopharma-reporter.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Mon, 26 Feb 2024 17:20:38 GMT
x-li-pop
afd-prod-lva1-x
x-msedge-ref
Ref A: EECEBBCA573F42F1B75633C26FF97269 Ref B: FRAEDGE1212 Ref C: 2024-02-26T17:20:39Z
linkedin-action
1
vary
Origin
x-cache
CONFIG_NOCACHE
x-li-fabric
prod-lva1
access-control-allow-origin
https://www.biopharma-reporter.com
x-li-proto
http/2
access-control-allow-credentials
true
x-li-uuid
AAYSTCDqV+mUmsbXyauQdQ==
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:830::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:39 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51115
x-xss-protection
0
server
cafe
etag
5598257657057689622
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Mon, 26 Feb 2024 17:20:39 GMT
pd.js
go.biopharma-reporter.com/
5 KB
2 KB
Script
General
Full URL
https://go.biopharma-reporter.com/pd.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.92.120.28 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-92-120-28.compute-1.amazonaws.com
Software
/
Resource Hash
41402adfc915ad6dfd6328c06c8038763d25fe603e63beba4a2638a2bbc03136

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

Date
Mon, 26 Feb 2024 17:20:39 GMT
content-encoding
gzip
X-Pardot-Route
e8229a0ff18ebffc83a98010d2521dd5
last-modified
Mon, 26 Feb 2024 05:25:41 GMT
etag
"15f4-gzip"
vary
Accept-Encoding,User-Agent
Content-Type
application/javascript
cache-control
max-age=63072000
Connection
keep-alive
accept-ranges
bytes
Content-Length
1988
expires
Wed, 25 Feb 2026 17:20:39 GMT
analytics
go.biopharma-reporter.com/
258 B
1 KB
Script
General
Full URL
https://go.biopharma-reporter.com/analytics?ver=3&visitor_id=&visitor_id_sign=&pi_opt_in=&campaign_id=null&account_id=959362&title=Biopharmaceutical%20Manufacturing%2C%20Upstream%2C%20Downstream%20processing%20news&url=https%3A%2F%2Fwww.biopharma-reporter.com%2F&referrer=
Requested by
Host: go.biopharma-reporter.com
URL: https://go.biopharma-reporter.com/pd.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.92.120.28 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-92-120-28.compute-1.amazonaws.com
Software
/
Resource Hash
2d8bcb085580484ca8c5bc841ac830003c04440adba57c47200cf19106acb0dd

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
Date
Mon, 26 Feb 2024 17:20:40 GMT
content-encoding
gzip
X-Pardot-Route
9b06e8e2308c32c7bf9ba8adfb7be2e1
x-pardot-rsp
0/0/1
vary
Accept-Encoding,User-Agent
Content-Type
text/javascript; charset=utf-8
p3p
CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml", CP="NOI DSP COR CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT", policyref="/w3c/p3p.xml"
cache-control
no-store, no-cache, must-revalidate
Connection
keep-alive
Content-Length
198
expires
Thu, 19 Nov 1981 08:52:00 GMT
sdk-runtime-config.js
buy.tinypass.com/api/v3/anon/assets/
279 B
522 B
XHR
General
Full URL
https://buy.tinypass.com/api/v3/anon/assets/sdk-runtime-config.js?aid=1f6nyjoJpu
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6812:dff8 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dda3e6a329077a80b3fb5ecfdaedad7f8533e1d459deb2a8f2d722dbed7eea94
Security Headers
Name Value
Strict-Transport-Security max-age=86400; includeSubDomains

Request headers

Accept
application/json
Referer
https://www.biopharma-reporter.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

date
Mon, 26 Feb 2024 17:20:41 GMT
strict-transport-security
max-age=86400; includeSubDomains
content-encoding
br
cf-cache-status
EXPIRED
p3p
CP="NON DSP COR OUR IND"
x-forwarded-https
on
alt-svc
h3=":443"; ma=86400
x-request-id
Mh64h9s55Vu
wn
prod-dash-10-0-139-117
last-modified
Sun, 25 Feb 2024 18:12:11 GMT
server
cloudflare
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
server-time
0.010
cache-control
public, max-age=14400
cf-ray
85b9dc32da9e2bf0-FRA
expires
Mon, 26 Feb 2024 21:20:41 GMT
analytics.js
www.google-analytics.com/
52 KB
21 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.biopharma-reporter.com
URL: https://www.biopharma-reporter.com/
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de36e50194320a7d3ef1ace9bd34a875a8bd458b253c061979dd628e9bf49afd
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
date
Mon, 26 Feb 2024 15:32:03 GMT
last-modified
Tue, 12 Dec 2023 18:09:08 GMT
server
Golfe2
age
6518
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
20994
expires
Mon, 26 Feb 2024 17:32:03 GMT
collect
www.google-analytics.com/j/
4 B
217 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j101&a=513911267&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.biopharma-reporter.com%2F&ul=en-us&de=UTF-8&dt=Biopharmaceutical%20Manufacturing%2C%20Upstream%2C%20Downstream%20processing%20news&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&ec=experienceExecute&el=Experience%20execute&_u=qCDAAEABAAAAACAAI~&jid=864457020&gjid=482474955&cid=1369008900.1708968038&tid=UA-5775678-46&_gid=237501456.1708968042&_r=1&_slc=1&z=875590624
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:806::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.biopharma-reporter.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:41 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/j/
4 B
151 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j101&tid=UA-5775678-46&cid=1369008900.1708968038&jid=864457020&gjid=482474955&_gid=237501456.1708968042&_u=qCDAAEAAAAAAACAAI~&z=1402717689
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c00::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.biopharma-reporter.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
date
Mon, 26 Feb 2024 17:20:41 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.biopharma-reporter.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.com/ads/
42 B
296 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-5775678-46&cid=1369008900.1708968038&jid=864457020&_u=qCDAAEAAAAAAACAAI~&z=1662632792
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:41 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
107 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j101&tid=UA-5775678-46&cid=1369008900.1708968038&jid=864457020&_u=qCDAAEAAAAAAACAAI~&z=1662632792
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://www.biopharma-reporter.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.69 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 26 Feb 2024 17:20:41 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Verdicts & Comments Add Verdict or Comment

134 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 function| getOTCookie object| expirationDate string| expirationDateString object| now object| OneTrustStub function| OptanonWrapper object| dataLayer function| svg4everybody object| wrbm_gb function| $ function| jQuery function| getCookie function| setCookie object| googletag string| interstitialAd boolean| displayInterstitialAd number| adsCount boolean| isInterstitial function| sanitizePianoTag string| acId object| relatedTagsPiano object| tp string| canonical object| dataLayerContent object| digitalData boolean| displayInterstitialAdConfig number| interstitialTimer1 function| interstitialCloseIt function| interstitialOpenIt object| countDownDate object| objDate string| locale string| month string| dayLong string| dayNum object| contentDate object| sectionDate function| debounce object| hinclude object| fos object| Routing function| PhotoSwipe function| PhotoSwipeUI_Default function| Picker object| __load_timer object| __load_events object| ___grecaptcha_cfg object| grecaptcha string| __recaptcha_api boolean| __google_recaptcha_client object| jwDefaults object| webpackChunkjwplayer function| jwplayer function| adBlockDetected function| adBlockNotDetected string| footerBgColor string| footerFontColor string| footerLinkColor string| footerLogoType function| getpub string| wrFooterBgColor string| wrFooterFontColor string| wrFooterLogoType number| wrFooterShowTC number| wrFooterShowPC number| wrFooterShowDT string| wrFooterLinkColor object| wrFooterLinksArray string| wrFooterLinks string| footerImageUrl string| footerRespStyle string| footerHTML string| piAId string| piCId string| piHostname object| google_tag_manager object| google_tag_data object| ggeac object| google_js_reporting_queue object| header object| widget undefined| findingMethod function| __tcfapi object| otStubData function| _typeof boolean| pnFullTPVersion number| pnInitPerformance boolean| pnHasPolyfilled object| pn string| __tpVersion object| SWG function| ___tp undefined| google_measure_js_timing object| previewParam string| _linkedin_data_partner_id function| fbq function| _fbq object| recaptcha object| cX function| cxCCE_callQueueExecute object| cxTest object| otIabModule object| Optanon object| OneTrust function| gtag string| OnetrustActiveGroups string| OptanonActiveGroups object| gaGlobal object| PianoESPConfig object| ari function| lintrk boolean| _already_called_lintrk undefined| cXJsonpCB1 object| ORIBILI function| checkNamespace function| getPardotUrl function| piTracker function| piGetParameter function| piGetCookie function| piSetCookie string| piVersion number| piScriptNum object| piScriptObj object| pi number| c_start string| property function| piResponse string| GoogleAnalyticsObject function| ga object| gaplugins object| gaData

33 Cookies

Domain/Path Name / Value
www.biopharma-reporter.com/ Name: cleared-wr-cookies
Value:
www.biopharma-reporter.com/ Name: __prestitial
Value: 1
www.biopharma-reporter.com/ Name: dnm_guestc
Value: 1708968037964-52kmqkgq-rajxvlmgz400
.biopharma-reporter.com/ Name: _pctx
Value: %7Bu%7DN4IgrgzgpgThIC4B2YA2qA05owMoBcBDfSREQpAeyRCwgEt8oBJAEzIBYB2AVgDYAjDwCcPAMxjRAJg4AGPtzEgAvkA
.biopharma-reporter.com/ Name: _pcid
Value: %7B%22browserId%22%3A%22lt37g1guka8vxlxu%22%7D
.biopharma-reporter.com/ Name: _pcus
Value: eyJ1c2VyU2VnbWVudHMiOm51bGx9
.biopharma-reporter.com/ Name: _ga_6SGBRT2KVQ
Value: GS1.1.1708968038.1.0.1708968038.60.0.0
.piano.io/ Name: __cf_bm
Value: sYMOHW1qVcly3ZHPZYJzHpK6IgNgpzQ_yTYO5O_JMII-1708968038-1.0-AbNYqJVJ7gRLfhgxuqzwbzUsRc7ok599+R7YxJ1uYq4BPoGMHSLaArcc/yyIWeWEiks7zKdSEoT1eJW1OtY4048=
.biopharma-reporter.com/ Name: _ga_GMENJXB1ZX
Value: GS1.1.1708968038.1.0.1708968038.60.0.0
.biopharma-reporter.com/ Name: __tbc
Value: %7Bkpex%7Dix4s1IP7sL35CbhPQMv7kFf4HuvPnHyfwvzkEk1uDxNUFOv75wwXafacF9Np34C9
.biopharma-reporter.com/ Name: __pat
Value: 0
.biopharma-reporter.com/ Name: __pvi
Value: eyJpZCI6InYtbHQzN2cxZ3loOWR1cGw3ZSIsImRvbWFpbiI6Ii5iaW9waGFybWEtcmVwb3J0ZXIuY29tIiwidGltZSI6MTcwODk2ODAzODI5N30%3D
.biopharma-reporter.com/ Name: xbc
Value: %7Bkpex%7D0IhYCiWqVh2BA1bBzOXzpUCl5UbOB87POR_dAGbgct0
.biopharma-reporter.com/ Name: OptanonConsent
Value: isGpcEnabled=0&datestamp=Mon+Feb+26+2024+18%3A20%3A38+GMT%2B0100+(Central+European+Standard+Time)&version=202401.2.0&browserGpcFlag=0&isIABGlobal=false&hosts=&consentId=1ae5649f-43d9-489a-92bc-70cd55e2b30d&interactionCount=0&landingPath=https%3A%2F%2Fwww.biopharma-reporter.com%2F&groups=C0001%3A1%2CC0003%3A0%2CC0002%3A0%2CC0005%3A0%2CC0004%3A0%2CV2STACK42%3A0
.biopharma-reporter.com/ Name: cX_P
Value: lt37g1guka8vxlxu
.biopharma-reporter.com/ Name: _fbp
Value: fb.1.1708968038548.675839586
.linkedin.com/ Name: li_sugr
Value: e42f3880-f652-47ad-9c59-d2b056a123d6
.linkedin.com/ Name: bcookie
Value: "v=2&e444b064-dc5f-43f4-840c-ea064e384670"
.linkedin.com/ Name: lidc
Value: "b=VGST09:s=V:r=V:a=V:p=V:g=2810:u=1:x=1:i=1708968038:t=1709054438:v=2:sig=AQEJ-onpXDevtyuAKVvvZ5Bhf3q73uh6"
.linkedin.com/ Name: UserMatchHistory
Value: AQIIsbRuBWL45gAAAY3mbtDda3hCdFll_sZSZKB1Axe0CLnHZv67kcOZK9cDoBj89wpPZWDOkJUxUA
.linkedin.com/ Name: AnalyticsSyncHistory
Value: AQL05JDYE5S1twAAAY3mbtDdWhyGHoh0qw7F3yusUMATaoVU107p_EtzC0RyHaThJwKk5BeUKEnNUO9LlMQLWQ
.cxense.com/ Name: gckp
Value: 2flb3g6a1k8ue11gxrrdve6yzd
.biopharma-reporter.com/ Name: cX_G
Value: cx%3A22ume76t3euor1fpk8gspp3sfv%3A1d07cn2l7p6pv
.www.linkedin.com/ Name: bscookie
Value: "v=1&202402261720382cef6a8b-3dff-4341-88c1-d4f918dc0696AQFxai88WTfyL65UHLytDdQOijXzrDne"
.linkedin.com/ Name: li_gc
Value: MTswOzE3MDg5NjgwMzg7MjswMjGd6u/BimcIEHzYGtafk8Q8fm8j51f897VHnq8WRwnHqw==
go.biopharma-reporter.com/ Name: visitor_id958362
Value: 344499647
go.biopharma-reporter.com/ Name: visitor_id958362-hash
Value: 5588c7f921e8a9e762d08bf33a4c1fac864851ba7b19e5b0d602f63bb4ab7260b7078873cc1965c1650244051e0d94d3fca21939
go.biopharma-reporter.com/ Name: lpv958362
Value: aHR0cHM6Ly93d3cuYmlvcGhhcm1hLXJlcG9ydGVyLmNvbS8%3D
www.biopharma-reporter.com/ Name: visitor_id958362
Value: 344499647
www.biopharma-reporter.com/ Name: visitor_id958362-hash
Value: 5588c7f921e8a9e762d08bf33a4c1fac864851ba7b19e5b0d602f63bb4ab7260b7078873cc1965c1650244051e0d94d3fca21939
.biopharma-reporter.com/ Name: _ga
Value: GA1.2.1369008900.1708968038
.biopharma-reporter.com/ Name: _gid
Value: GA1.2.237501456.1708968042
.biopharma-reporter.com/ Name: _gat_pianoTracker
Value: 1

42 Console Messages

Source Level URL
Text
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://connect.facebook.net/signals/config/646689182168886?v=2.9.147&r=stable&domain=www.biopharma-reporter.com&hme=20c913bdcd4be51a752120153aa5caaecb3ee86c7f26cf737846e40b202aba68&ex_m=62%2C106%2C94%2C98%2C53%2C3%2C88%2C61%2C14%2C86%2C79%2C44%2C46%2C150%2C153%2C164%2C160%2C161%2C163%2C25%2C89%2C45%2C68%2C162%2C145%2C148%2C157%2C158%2C165%2C115%2C13%2C43%2C169%2C168%2C117%2C16%2C29%2C32%2C1%2C36%2C57%2C58%2C59%2C63%2C83%2C15%2C12%2C85%2C82%2C81%2C95%2C97%2C31%2C96%2C26%2C22%2C146%2C149%2C124%2C24%2C9%2C10%2C11%2C5%2C6%2C21%2C19%2C20%2C49%2C54%2C56%2C66%2C90%2C23%2C67%2C8%2C7%2C71%2C41%2C18%2C92%2C91%2C17%2C4%2C73%2C80%2C72%2C78%2C40%2C39%2C77%2C33%2C35%2C76%2C48%2C74%2C28%2C37%2C65%2C0%2C84%2C75%2C2%2C30%2C55%2C34%2C93%2C38%2C70%2C60%2C99%2C52%2C51%2C27%2C87%2C50%2C47%2C42%2C69%2C64%2C100(Line 95)
Message:
Unrecognized feature: 'attribution-reporting'.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.
other warning URL: https://www.biopharma-reporter.com/
Message:
Third-party cookie will be blocked. Learn more in the Issues tab.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

assets.adobedtm.com
buy.tinypass.com
c2.piano.io
cdn.cookielaw.org
cdn.cxense.com
cdn.jwplayer.com
cdn.tinypass.com
comcluster.cxense.com
connect.facebook.net
experience.tinypass.com
fonts.googleapis.com
fonts.gstatic.com
footer.wrbm.com
geolocation.onetrust.com
go.biopharma-reporter.com
id.cxense.com
p1cluster.cxense.com
pagead2.googlesyndication.com
px.ads.linkedin.com
px4.ads.linkedin.com
region1.analytics.google.com
resources.wrbm.com
securepubads.g.doubleclick.net
snap.licdn.com
stats.g.doubleclick.net
www.biopharma-reporter.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.gstatic.com
www.linkedin.com
13.107.42.14
13.80.151.158
151.101.194.137
151.101.66.137
167.235.124.59
2001:4860:4802:32::36
2600:9000:225e:c800:1:a3fa:7cc0:93a1
2606:4700:4400::ac40:9b77
2606:4700::6811:c276
2606:4700::6812:83ec
2606:4700::6812:907e
2606:4700::6812:dff8
2620:1ec:21::14
2a00:1450:4001:800::200a
2a00:1450:4001:806::200e
2a00:1450:4001:809::2003
2a00:1450:4001:80b::2003
2a00:1450:4001:810::2003
2a00:1450:4001:812::2008
2a00:1450:4001:827::2002
2a00:1450:4001:82f::2004
2a00:1450:4001:830::2002
2a00:1450:400c:c00::9b
2a02:26f0:3500:16::215:1484
2a02:26f0:480:7a5::1e80
2a02:26f0:480:ba2::268b
2a03:2880:f007:8:face:b00c:0:1
2a03:2880:f176:181:face:b00c:0:25de
3.92.120.28
34.107.184.21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